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Summary 
   
My PhD thesis focuses on the structure analysis of proteins by X-ray crystallography, 
namely bacterial membrane proteins from the family of ABC transporters, the 
inflammasome adaptor protein SGT1 and Designed Ankyrin Repeat Proteins. These 
three topics will be summarized below. 
 
Several ABC-transporters of Escherichia coli have been selected for recombinant 
expression and purification. By screening of several constructs and expression 
conditions the ABC-transporters YojI, MclB and HlyB were expressed. The 
purification protocol for the microcin exporter YojI was optimized and it was shown 
that YojI forms a stable dimer. This protein was used for functional assays. The 
obtained results form the basis for an increased understanding of the function of 
ABC-transporters. 
 
The human protein SGT1 was expressed and characterized by biophysical methods. 
This protein is involved in the pathogen defence reactionin the mammalian 
immunesystem and its planhomologue is involved in the hypersensitivity response. 
Since the full length protein SGT1 did not yield crystals, we used limited proteolysis 
to obtain fragments that might be amendable for crystallization. Several fragments 
were obtained, cloned and overexpressed. For the central CS-domain an X-ray 
structures became available during my PhD thesis, for the N-terminal TPR domain 
structures of homologues were elucidated. The C-terminal SGS-domain revealed a 
limited degree of folding. The gained information is useful for further immuno-assays 
in order to determine interaction partners.  
 
  Summary 
  
  5 
Selected Designed Ankyrin Repeat Proteins (DARPins) were structurally analysed. 
DARPins are extremely stable repeat proteins having a vast field of application as 
inhibitors and as crystallization aids. Previous studies have shown that the C-terminal 
capping repeat is limiting the stablility of these molecules. Therefore the group of 
Prof. A. Plückthun designed new C-terminal caps that showed improved thermal 
stability. To analyse the structural determinants for this improved thermal stability 
the DARPins NI1C mutant 4, NI3C mutant 5 and NI3C mutant 6 were crystallized.  
The crystal structures revealed an improved packing between the C-terminal capping 
repeat and the last internal repeat explaining the improved thermal stabilityof the 
new design.  
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Zusammenfassung 
 
Meine Dissertation beschäftigt sich mit der Röntgenstrukturanalyse von Proteinen. 
Zu diesen gehörten Mitglieder der Familie der ABC-transporter, das Inflammasome-
Adapter-Protein SGT1 und den sogenannte Designed Ankyrin Repeat Proteins, 
welche folgend kurz beschrieben werden.   
 
Eine Auswahl ABC-Transporter aus dem Organismus Escherichia coli wurde 
selektioniert, um eine einfache Expression zu gewährleisten. Bei dem Screening von 
verschiedenen Konstrukte und Expressionsbedingungen konnten die ABC-transporter 
YojI, MclB und HlyB expremiert werden. Es wurde gezeigt, dass der Microcin-
exproter YojI ein stabiles Dimer bildet welcher für funktionelle Analysen genutzt 
wurde. Die hieraus hervorgegangenen Resultate werden eine Basis für das 
Verständnis der Funktion der ABC-Transporter von Nutzen sein. 
 
Das humane Protein SGT1 wurde aufgereingt und durch biophysikalische 
Messmethoden charakterisiert. Dieses Protein ist in der Abwehrreaktion von 
Pathogenen in der Immunantwort des Säugetiers und sein pflanzliches Homolog in 
der so genannten Hypersensitivitätsreaktion  beteiligt. Da das Protein SGT1 keine 
Kristalle bildete, wurden mit Hilfe von limitierten Proteolyseversuchen Fragmente 
bestimmt, welche die Kristallbildung vereinfachen sollen. Die dabei erhaltenen 
Fragmente wurden kloniert und aufgereinigt. Während dieser Arbeit wurde eine 
Struktur der mittleren CS-Untereinheit mittels Röntgenstrukturanalyse bestimmt, für 
die amino-terminale TPR-Untereinheit wurden Strukturen von Homologen bekannt. 
Die carboxy-terminale SGS-Unterinheit zeigte einen beschränkten Anteil an Faltung. 
Die erhaltenen Informationen können für die Ermittlung von Interaktionspartnern 
durch Immunoassays dienen. 
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Ausgewählte Designed Ankyrin Repeat Proteins (DARPins) wurden 
strukturbiologisch analysiert. DARPins sind extrem stabile Proteine welche aus sich 
wiederholenden Aminosäuresequenzen bestehen. Diese Proteine zeichnen sich durch 
eine weit gefächerte Anwendungsvielfalt aus, wie zum Beispiel ihr Nutzen als 
Inhibitoren und als Kristallisationshilfen. Vorangegangene Studien zeigten, dass die 
C-terminal Wiederholung die Stabilität dieser Moleküle limitiert. Deshalb entwarf 
die Gruppe von Prof. A. Plückthun diese C-terminale Wiederholung neu, ihre 
Resultate wiesen erhöhten thermischen Stabilitäten auf. Um die strukturellen 
Faktoren für diese verbesserte Stabilitäten zu bestimmen, wurden die DARPins NI1C 
mutant 4, NI3C mutant 5 and NI3C mutant 6 kristallisiert. Die 
Röntgenkristallstrukturen zeigten eine dichtere Packung der carboxy-terminalen 
Wiederholung zu der letzten internen Wiederholung. Dieses Verhalten erklärt die 
verbesserte thermische Stabilität des neuen Designs. 
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List of abbreviations 
 
α2β2 motif    motif comprising two antiparallel α -helices and a β-turn 
ABC transporter   ATP Binding Cassette transporters 
AcrB    Acriflavine resistance protein B 
ADP     Adenosine-Di-Phosphate 
Amp     Ampicillin 
AMP-PNP    Adenylyl-imidodiPhosphate 
APH     Aminoglycoside Phosphotransferase  
ASC    Apoptosis-associated Speck-like protein  
ASU    Asymmetric unit 
At    Arabidopsis thaliana 
ATP    Adenosine-Tri-Phosphate 
BIR    Baculoviral Inhibitor of apoptosis Repeats 
CARD    Caspase Recruitment Domain 
CC domain   Coiled-Coiled domain  
C-cap    Carboxy-terminal capping repeat 
CD    Circular Dichroism  
CFTR     Cystic Fibrosis Transmembrane Conductance Regulator  
CHAPS 3-[(3-Cholamidopropyl)-dimethylAmmino]-1 
Propanesulfonate  
CHORD   Cysteine and Histine Rich Domain containing protein 
CIITA    MHC Class II TransActivator      
ColV    Colicin V 
CS domain    CHORD and SGT1 motif containing domain 
C-terminus    Carboxy-terminus 
CV     Column Volume 
Cymal 6   6-Cyclohexyl-1-hexyl-β-D-Maltoside  
Cymal 7   7-Cyclohexyl-1-hexyl-β-D-Maltoside 
DARPin   Designed Ankyrin Repeat Protein  
DDM    n-Dodecyl-β-Maltopyranoside 
DM    n-Decyl-β-Maltopyranoside  
DNA    Deoxyribonucleic acid  
DTT     Dithiothreitol 
E. coli    Escherichia coli 
EDTA     Ethylene Diamine Tetra Acidic acid 
EPR spectroscopy   Electron Paramagnetic spectroscopy 
ESI    ElectroSpray Ionization 
Fos 12    n-Dodecylphosphocholine 
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Fos 14    n-Tetradecylphosphocholine 
Fos 16    n-Hexadecylphosphocholine 
GABPβ1   Guanine-Adenine Binding Proteinβ1 
HEPES   4-(2-Hydroxyethyl)-1-PiperazineEthaneSulfonic acid 
HlyB    ABC transporter exporting Haemolysin A 
HR    Hypersensitivity Response 
Hs    Homo sapiens 
HSP90    Heat Shock Protein 90 
Hv    Hordium vulgare 
ICE    Interleukin-1β converting enzyme  
IL    Interleukin 
IM    Inner Membrane  
IPTG    Isopropyl-β-D-ThioGalactopyranoside 
IR    Internal Repeat 
Kan     Kanamycin 
kDa     kilo Dalton 
LB media   Luria-Bertani media 
LDAO    Lauryl-DimethylAmino-Oxide     
LPS    LipoPolySaccharide 
LRR    Leucine Rich Repeat 
MALDI   Matrix Assisted Laser Desorption Ionizaton  
MC RMSD   Main Chain Root Mean Square Deviation  
Mcc     Microcin 
MchF  Microcin exporting protein F exporting the microcin 
H45 
McjD    Microcin exporting protein D exporting the microcin D 
MclB    Microcin exporting protein B exporting the microcin L 
MD    Molecular Dynamics 
MDP    Muranyldipeptide 
MDR    Multi Drug Resistance transporter  
MFP    Membrane Fusion Protein 
MHC    Major Histocompatibility Complex   
MS    Mass Spectroscopy 
MW    Molecular Weight 
NACHT domain   NAIP, CIITA, HET-E and TP1 domain  
NAIP    NLR family, apoptosis inhibitory protein 
NALP     NACHT-, LRR- & Pyrin-domain containing proteins 
NBD    Nucleotide Binding Domains  
NI1C    DARPin containing 1 internal repeat 
NI3C    DARPin containing 3 internal repeats  
Ni-IMAC column  Nickel-Immobilized Metal Affinity Chromatography 
  List of abbreviations 
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NLR    NBD LRR containing Receptors 
NLRA    NLR family containing Acidic Domains 
NLRB    NLR family containing BIR Domains 
NLRC    NLR family containing CARD Domains 
NLRP    NLR family containing Pyrin Domains 
NLRX NLR family without strong homology to N-terminal 
domains of other NLRs 
NMR spectroscopy  Nuclear Magnet Resonance spectroscopy 
NOD Nucleotide-binding Oligomerization Domain containing 
protein 
NOESY   Nuclear Overhauser Enhancement Spectroscopy 
N-terminal    amino-terminal 
OD    Optical Density 
OG    n-Octyl-β-Glucopyranoside 
OM    Outer Membrane   
OM    n-Octyl-β-Maltopyranoside 
Os    Oryza sativa 
OTG    n-Octyl-β-D-ThioGlucopyranoside 
PAMP    Pathogen-Associated Molecular Patterns 
PBP    Periplasmic Binding Protein  
PDB     Protein Data Bank 
PGN    PeptidoGlycan  
Pgp     P-glycoprotein  
Plk-1    Polo-like kinase 1 
PRR    Pathogen-Recognition Receptor 
PYD    PYrin Domain  
RAR1    Required for MLA12 Resistance protein 
RIP    Receptor Interacting Protein 
RNA     RiboNucleic Acid 
RP    Repeat proteins   
Sc    Saccharomyces cerevisiae 
SC    Shape Complementarity 
scFabs    single chain antibody Fragments 
SD    Standard Deviation 
SDS    Sodium Dodecyl Sulphate 
SDS-PAGE    SDS-Poly Acrylamide Gel Electrophoresis 
SEC     Size Exclusion Chromatography  
SGS domain   SGT1 Specific domain 
SGT1    suppressor of the G2 allele of skp1 
SLS    Static Light Scattering 
TAP     Transporter associated with Antigen Presentation  
  List of abbreviations 
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TCEP    Tris(2-CarboxyEthyl)Phosphine 
Tet    Tetracyclin 
TLR    Toll-Like Receptors  
TMD    TransMembrane Domain 
TPR    Tetratrico Peptide Repeat  
Tris    Tris(hydroxymethyl)-aminomethan 
UDM    n-UnDecyl-β-Maltopyranoside 
VR    Variable Region 
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Chapter A - ABC transporter  
A.I Introduction  
A.I.1 General Overview 
The transport of solutes across the biological membrane is an essential prerequisite for 
the survival and functioning of both prokaryotic and eukaryotic cells. Approximately 
a third of the proteins of a cell are membrane spanning proteins, of which one 
important family are the ATP binding cassette (ABC) transporters. They transport 
solutes over the cellular membrane under the consumption of ATP. 
Members of this family can function as channels, importers or exporters. Up to now 
ABC importers are only known in prokaryotes, whereas ABC exporters are 
characterized in both, prokaryotes and eukaryotes (Davidson 2008). 
Their activities are required for various processes essential to cells, such as the 
uptake of nutrients (examples are sugars, ions, amino acids), osmosensing and -
regulation as well as antigen processing. Multidrug resistance, a major clinical 
problem in the treatment of human cancers, as well as bacterial and fungal infections, 
are mediated by this transporter class. In addition to this, the dysfunction of an ABC 
transporter forms the molecular basis of several inherited human diseases, including 
cystic fibrosis, bile salt disorders and adrenoleukodystrophy (Dean and Allikmets 
1995). This protein class is therefore of high biomedical interest. 
So far about 48 human ABC transporters have been characterized (Dean, 
Rzhetsky et al. 2001). They are classified in 6 different subfamilies (ABCA, ABCB, 
ABCC, ABCD, ABCE/ABCF and ABCG). The subfamily ABCA can be subdivided in 
two phylogenetic groups. The first group comprises ABCA1, ABCA2, ABCA3, 
ABCA4, ABCA7, ABCA12, ABCA13; the second group contains ABCA5, ABCA6, 
ABCA 8, ABCA9 and ABCA10, all clustered on the same chromosome. 
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A well known ABC transporter is the Cystic Fibrosis Transmembrane Conductance 
Regulator (CFTR), a chloride ion channel, belonging to the subfamily ABCC (Quinton 
1999). Members of the subfamily ABCB are the well studied multidrug resistance 
transporter ABCB1 also named P-glycoprotein or Pgp (Rosenberg, Callaghan et al. 
1997) and TAP involved in antigen presentation (Muller, Ebensperger et al. 1994). 
ABCA1 is known for cholesterol transport disorders and high-density lipoprotein 
biosynthesis (Dean, Rzhetsky et al. 2001).  
 
A.I.2 Domain Arrangement in the different ABC-transporters 
ABC transporters are composed of two transmembrane domains (TMD) being 
responsible for the substrate transport across the membrane and two nucleotide 
binding domains (NBD), that are located in the cell interior and fuel by binding and 
hydrolyzing ATP (Figure A.1). 
TMD
NBD
 
Figure A.1) The structure of the ABC transporter Sav1866 of Staphylococcus aureus in its outward-
facing conformation representing the ATP-bound state (Dawson and Locher 2006). The two monomers 
are coloured in green and blue respectively. The bound nucleotide ADP is shown in red spheres. 
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Figure A.2 displays different domain organizations observed in the ABC 
transporter superfamily  (reviewed by (Locher 2009), (Higgins 1992), (Rees, Johnson 
et al. 2009)).  
In importers, the four domains assemble as four independent polypeptide 
chains to form the functional transporter (Figure A.2a). In addition, a periplasmic 
binding protein (PBP) is required that captures the substrate in the periplasm and 
delivers it to the ABC importer. Examples for ABC importers are the vitamine B12 
uptake system BtuCD, which is the first solved structure of an ABC transporter 
(Locher, Lee et al. 2002), or the maltose uptake system of E.coli (Oldham, Khare et al. 
2007). The TMDs of the structurally and functionally diverse ABC importers consist 
of 5 to 10  transmembrane helices (Rees, Johnson et al. 2009). The TMD of exporters 
in contrast always consist of 6 transmembrane helices and are fused to a NBD forming 
a half transporter (Figure A.2c). Two half transporters 
 
                          
           
Figure A.2) Different structural domain organization found in ABC-transporters. The cytosolic NBD is 
coloured in green, the TMD is coloured in light blue. The PBP is coloured in orange. a) All domains are 
expressed as single polypeptides, as found in ABC-importers having a PBP; b) All domains are fused to 
one polypeptide chain; c) two half transporter consisting of a TMD-NBD fusion form the functional 
unit. 
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homo- or heterodimerize to form the active ABC transporter, like in the case of the 
recently solved X-ray structures of Sav1866 of Staphylococcus aureus (Dawson and 
Locher 2006) and the lipid flippase MsbA (Ward, Reyes et al. 2007). Also the 
transporters discussed in this work, the bacterial ABC transporter YojI, and the 
microcin exporters MclB and MchF share this architecture.  
In eukaryotes, all four domains are usually fused to a single polypeptide chain, 
as for instance in the prominent examples of the human multidrug resistance 
transporter MDR and CFTR (Higgins 1992) (Figure A.2b) . 
ABC dimers devoid of TMDs also exist and are involved in DNA repair (e.g., RecA 
(Story and Steitz 1992) and Rad50 (Hopfner, Karcher et al. 2000)). 
 
A.I.3 Structural Motifs in ABC transporters 
The NBDs display a high degree of homology (up to 30 % sequence identity (Holland 
and Blight 1999)) and contain a number of conserved sequence motives that are 
required for the binding and hydrolysis of ATP (Figure A.3). 
The arrangement of the two sub domains of the NBD are assembled as two 
lobes standing rectangular on each other. The first domain is the so called RecA like 
domain (Walker, Saraste et al. 1982). The second one is named helical sub-domain 
and consists of three to four helices. In the presence of ATP, the NBDs dimerize in a 
head-to-tail conformation; the RecA-like domain of one NBD is facing the helical 
sub-domain of the counterpart and thereby forms a catalytic site involved in ATP 
hydrolysis.  
The helical subdomain and the RecA-like domain are linked by the so called 
Q-loop, containing a highly conserved glutamine: This loop interacts with the TMD 
of the full transporter and assures the transmission of the energy obtained by ATP 
hydrolysis to a structural reorganization of the transmembrane domain, resulting in a 
different conformation in the translocation path of the transported substrate. 
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Figure A.3) Structural alignment of the NBD of HisP of S. typhimurium, MalK from E. coli, MJ0796 
and MJ1267 from Methanococcus jannaschii and YojI of E. coli. The characteristic motifs are coloured. 
Predicted secondary structure elements, as predicted by JPRED for the NBD of YojI are depicted.  
 
Before the hydrolysis reaction takes place, ATP is bound in a sandwich-like fashion 
between the Walker A motif (GxxGxGKS/T, x is any amino acid), of the cis-monomer 
and the ABC signature motif, the so called LSGGQ motif, of the trans-monomer. The 
cofactor Mg2+ is coordinated by the aspartate of the Walker B motif and is crucial for the 
hydrolysis reaction.  The lysine of the Walker A motif,  the histidine of the H-loop and 
the glutamate of the Walker B motif form a charge network with the phosphate moiety of 
ATP and play a key role in ATP hydrolysis. 
 
A.I.4 The ATPase cycle 
Despite extensive studies on isolated NBDs, and the crystal structures of several full 
transporters, the catalytic cycle of ATP hydrolysis and the energy coupling to the 
substrate transport in the TMDs are still controversially discussed in the literature.  
Two models are debated how the ATP hydrolysis is coupled to the transport reaction.  
The first model was proposed by Higgins and co-workers (Higgins and Linton 2004) 
in which the ATP binding and hydrolysis induces the formation and dissociation of 
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the NBD dimer, respectively. The NBD dimerization is proposed as the regulatory 
switch, being responsible for conformational changes in the TMDs that consequently 
decrease the affinity for the binding of the substrate and allows for drug release to the 
cell exterior.  
A second model is based on observations with vanadate induced trapping of ATP in 
P-glycoprotein. These experiments gave evidence that only 1 ATP can be trapped in 
one Pgp dimer by vanadate (called ATP occlusion) and suggested that only 1 ATP can 
be hydrolyzed at the same time (Urbatsch, Sankaran et al. 1995). The occlusion of the 
ATP was shown to induce the conformational switch, resulting in the high to low 
affinity transition of the TMDs to the substrate, which is consequently transported 
out of the cell (Sauna and Ambudkar 2007), as depicted in Figure A.4 (reviewed by 
(Seeger and van Veen 2009)). 
  
occlusion ATP-
hydrolysis
ATP-
hydrolysis
 
Figure A.4) The occlusion induced switch model as established by senior and co workers. The 
occlusion of ATP is necessary for the hydrolysis reaction and decreases the affinity for the substrate, 
which is then liberated. Subsequently ADP is released. Either the second ATP is hydrolysed or a new 
ATP molecule can be bound. Substrate can bind again, so that a new transport reaction can be started 
(red = ATP, green=ADP). 
 
ABC-transporters  Introduction 
  
  18 
Crystal structures revealed the conformational changes taking place during the 
transport cycle of ABC exporters. 
In the crystal structure of Sav1866, crystallized in an outward facing conformation in 
the presence of ADP or AMP-PNP (Dawson and Locher 2006) the membrane helices 
are split up into two wings. The substrate is proposed to escape either to the periplasm 
or to the outer leaflet of the membrane, whereas the NBDs are displaying tight dimer 
interactions. Two coupling helices form the transmission interface between the TMDs 
to the NBDs and assure the transmission of the structural rearrangement from the 
NBDs to the TMDs by non-covalent interactions (Dawson and Locher 2006). 
More information on the possible conformational repertoire of ABC exporters 
is available for the lipid flippase MsbA that was crystallized in three different 
conformations: an opened apo form, a closed apo-form and a closed nucleotide-bound 
form (Ward, Reyes et al. 2007). The latter one was crystallized either in the presence 
of Mg-Vi-ADP or with two AMP-PNP (Borbat, Surendhran et al. 2007). In the 
absence of nucleotides, the transporter adopts an inward-facing conformation and the 
substrate is proposed to be accommodated either from the cytoplasm or the inner 
leaflet of the cell membrane. In the closed apo-form, the NBDs are in closer proximity 
whereas in the closed nucleotide bound conformation, the NBDs dimerize and the 
TMDs are in an outward facing conformation, comparable to the structure of 
Sav1866. EPR spectroscopy and site-directed spin-labeling are in support of the 
conformations of MsbA found in the X-ray structures (Borbat, Surendhran et al. 
2007). 
These conformational changes are in agreement with the alternate access and release 
model that was also postulated for Sav1866 (Dawson and Locher 2006). 
A.I.5 Microcin-exporter   
Microcins as well as colicins are bacteriocins produced by E. coli. In contrast to 
colicins, microcins are non-lethal to their producing strain but they inhibit the 
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growth of closely related strains. These microcins have a molecular weight of less 
than 10 kDa (reviewed by (Pons, Delalande et al. 2004)) and can be divided in two 
classes, according to their size and modifications. 
Class I microcins (Mcc) are post-translationally modified and are targeted on 
intracellular processes. They have a molecular mass of less than 5 kDa. Mcc B17, Mcc 
C7, Mcc J25 and possibly Mcc D93 all belong to this group.  
To the second class belong microcins with a molecular mass between 7-10 kDa. Mcc 
E492, Mcc L, Mcc H47 and Mcc V are firmly apart of the class II group. (reviewed by 
(Pons, Lanneluc et al. 2002; Pons, Delalande et al. 2004). 
 In general, four clustered genes, grouped in one or two operons encode the 
machinery for the production and export of microcins. The genes encode the 
precursor peptide, an immunity protein conferring resistance against the microcine, 
the microcin exporter and the membrane fusion protein (MFP). It is believed that a 
tripartite assembly assures the export of the substrate out of the bacterial cell, as seen 
for the ColV secretory complex (Figure A.5) ((Azpiroz, Rodriguez et al. 2001; Pons, 
Delalande et al. 2004). The transporter protein itself is located in the inner membrane 
(IM) of E. coli. For the secretion of a toxin, it requires TolC, an outer membrane 
protein, mediating the transport of the toxin through the outer membrane (OM) and 
the MFP creating an IM-OM bridge (Hwang, Zhong et al. 1997).  
The microcin Mcc J25 belongs to the small class I microcins. It is synthesized 
from a 58 amino acid long precursor and after processing, the active toxin is 21 amino 
acids long and forms a so called lariat ring as seen in Figure A.5b (Blond, Cheminant 
et al. 2001). The microcin J25 is plasmid-encoded together with its associated ABC 
transporter McjD  (Delgado, Vincent et al. 2005). However, Mcc J25 has been shown 
to be transported by YojI as well (Delgado, Vincent et al. 2005) . 
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The microcins MccH47 and MccL are two examples for class II microcins. 
They possess a leader sequence, which is cleaved upon externalization. The dedicated 
microcin exporters MclB and MchF have a protease domain which is fused to 
a)        b) 
        
 
Figure A.5) a) The export of the microcinJ25 (Vincent and Morero 2009). The MccJ25 Synthase 
processes the MccJ25 precursor, in order to obtain its characteristic lasso structure. This microcin can 
be exported by the ABC-transporter McjD or YojI. The accessory proteins are unknown. b) The 
microcine J25 as determined by NMR (Blond, Cheminant et al. 2001) 
 
the N-terminus of the transporter, assuring the leader sequence cleavage (Havarstein, 
Diep et al. 1995).  
 
The ABC transporter focused on in this PhD thesis is YojI from E. coli (Kobayashi, 
Nishino et al. 2001). It is a typical homodimeric ABC exporter mediating the export of 
the microcin J25. So far, the MFP interacting with YojI is still unknown. Additional 
ABC-transporters were examed in this thesis, namely the exporter of Haemolysin A 
(HlyB), and the bacteriocin exporters of the class II microcins L (MclB) and H47 
(MchF) from E. coli. 
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A.II Results  
A.II.1 Selection of the transporters 
 The main goal of this project of the PhD thesis was to purify ABC transporters at 
high yield that are stable in detergent solution in order to determine the three 
dimensional structure by X-ray crystallography. Since the purification and 
crystallization is known to be tedious and sometimes even impossible for a multitude 
of membrane proteins, several ABC transporters were examined in this study. 
The focus was on ABC exporters, in particular the hemolysin exporter HlyB and the 
microcin exporters MclB, MchF and YojI. The aim was to choose half transporters, 
having the NBD fused to the C-terminus of the transmembrane domain in order to 
facilitate a straightforward cloning and purification procedure. The transporter MclB 
and MchF have an additional N-terminal proteolytic domain fused to the N-terminus, 
as depicted in Figure A.6. This domain cleaves the double-glycine leader of class II 
microcines.  
                           
 
 
 
Figure A.6) Scheme of the ABC half transporter MclB. It possesses 6 transmembrane helices. The 
NBD, is fused to the C-terminus.  The proteolytic domain is located at the N-terminus.   
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The genes were cloned by standard techniques in a subset of vectors. Cloning of 
mchE/F was unsuccessful presumable due to toxicity problems caused by the 
expression of this protein in E. coli.  
The constructs used in this chapter are listed in Table A.1, showing also whether the 
respective transporter was expressed and purified. 
 
 
 
Table A.1) Expression constructs of ABC-transporters used in this project. The expression conditions 
and the expression level of the respective protein are enlisted.   
 
 
Gene 
(E. coli 
strain of 
origin) 
Vector Remark Expression hosts Protein 
production 
(Western blot or 
dot blot) 
Protein 
purification 
mclB 
(LR05) 
pBAD24 C-
terminal 
His6-tag 
E. coli  
BL21(DE3) 
BL21(DE3)-AI 
C41(DE3) 
C43(DE3) 
 
- 
 
Not purified 
mclB 
(LR05) 
pET28 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
DH5α 
 
+ Dot Blot 
weak band on  
Western Blot 
 
Not purified 
mclB 
(LR05) 
pET28 N-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
-  
 
Not purified 
mclB 
(LR05) 
pET21 C-
terminal 
His6-tag 
E. coli  
BL21(DE3) 
BL21(DE3)plys 
C41(DE3) 
C43(DE3) 
DH5α 
 
- 
 
Not purified 
mclB 
(LR05) 
pET21 N-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
- 
 
Not purified 
hlyB 
(CFT07) 
pET21 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
+ Western Blot 
 
Low yield, after 
Ni-NTA 
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Gene 
(E. coli 
strain of 
origin) 
Vector Remark Expression hosts Protein 
production 
(Western blot or 
dot blot) 
Yield of purified 
protein 
hlyB 
(536) 
pET21 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
-  
 
Not 
Purified 
hlyB 
(536) 
pET21 N-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
- 
 
Purified 
hlyB 
(536) 
pET28 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
+ Dot Blot 
+ Western Blot 
 
Low yield, after 
Ni-IMAC 
hlyB 
(536) 
pET28 N-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
C41(DE3) 
C43(DE3) 
 
- 
 
Not purified 
hlyB 
(CFT07) 
pBAD24 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
 
 
- 
 
Not purified 
hlyB 
(536) 
pBAD24 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
 
 
- 
 
Not purified 
mchE/F 
(CA58) 
pBAD24 C-
terminal 
His6-tag 
E. coli   
BL21(DE3)-AI 
 
 
- 
 
Not purified 
mchE/F 
(CA58) 
pET21 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
 
- 
 
Not purified 
YojI 
(CFT07) 
pET28 C-
terminal 
His6-tag 
E. coli   
BL21(DE3) 
 
+ Dot Blot 
+ Western Blot 
 
Purified 
 
For the three ABC transporters YojI, MclB and HlyB, protein expression could be 
demonstrated by Dot blotting and Western blotting (Figures A.7 and A.8). For YojI, 
protein production could be observed under all tested conditions, whereas only a 
weak signal was detectable for MclB after 4h expression time at a temperature of 30°C 
(Figure A.7a). The expression levels of YojI were sufficient to purify the protein to 
homogeneity (see below). For MclB, a band at an apparent molecular weight of 70 
kDa was detected which agrees with its expecected molecular weight of 76.8 kDa 
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(Figure A.7b). Likewise, protein expression could be demonstrated for HlyB with a 
number of constructs (Figure A.8). The expression yield of MclB however, was too 
low to allow for protein purification. 
Figure A.7) Screening for expression conditions for the ABC-transporters MclB and YojI a) Dot Blot of 
culture samples expressing YojI or MclB as compared to a negative control (NC), which were taken 
after 0, 2 and 4h after induction at the temperatures of 20°C and 30°C.  b) Western Blot analysis of cells 
expressing MclB taken at 4 h after induction at 30°C. The proteins were detected with a scFv antibody 
selective for the His-tag. 
 
Figure A.8) Western Blot analysis of HlyB expressed from different vectors in E. coli BL21(DE3).  
a) b) 
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A.II.2 Purification of the constructs of the ABC-transporter 
YojI turned out to be the only expressing transporter that could be purified yielding 
reasonable amount of pure protein.  Therefore it was decided to carry out a thorough 
screening on buffer compositions and detergents with the ultimate aim to obtain a 
high yield of stable, non-aggregated and functional dimeric protein. 
A.II.2.a Optimization of the buffer conditions for YojI of E.coli 
The initial purification protocol, using the buffer containing 20 mM NaCl pH 7.5, 0.03 
% DDM yielded highly pure protein (Figure 9b). However, when the protein was 
separated by size exclusion chromatography (SEC), aggregation was observed (Figure 
A.9a). Notably, a peak corresponding to the Yoji dimer could be collected 
(Sennhauser 2004), that was prone to aggregation upon prolonged storage as judged 
by size exclusion chromatography (not shown).  
Therefore, different buffers covering a pH range between pH 6.5 and pH 7.5 were 
used to purify the protein, in order to determine conditions under which the protein 
is less prone to aggregation (Table A.2). 
 
7 elution volume 14 [ml]
[mAU]
950
0
A280
MW
[kDa]
100
85
70
60
50
40
30
25
Aggregation
Peak
Dimer
Peak
  
Figure A.9) Initial purification attempt of YojI in 20 mM Tris, 150 mM NaCl pH 7.5, 0.03 % DDM. a) 
Size exclusion chromatogram. b) SDS-PAGE analysis of the YojI fractions marked in red in pannel a)  
 
b) a) 
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Table A.2) Buffer screen using size exclusion chromatography in order to reduce the aggregation of 
YojI. 
 
Buffer, pH, detergent (3X CMC) Ratio  between dimer peak and aggregation 
peak (peak height) on SEC 
20 mM Tris, 7.5, DDM 40:60 
20 mM Citrate, 6.4, DDM 80:20 
20 mM HEPES 7.5, DDM 0:100 
20 mM KPi, 7.5, DDM 0:100 
20 mM KPi, 7.2, DDM 0:100 
20 mM KPi, 7.0, DDM 20:80 
20 mM KPi, 6.5, DDM 0:100 
20 mM Citrate, 6.8, 500 mM NaCl, DDM 40:60 
20 mM Citrate, 6.8, Glycerole Cymal 7 60:40 
20 mM Citrate, 6.4 Cymal 7 80:20 
20 mM Citrate, 7 Cymal 7 80:20 
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Figure A.10) Size exclusion chromatography of the ABC-transporter YojI of E. coli  using 20 mM Na-
Citrate, 150 mM NaCl, 0.03 % DDM pH 6.4 
ABC-transporters  Results 
  
  27 
The purification yielding the best peak separation and the smallest amount of 
aggregated protein was obtained in 20 mM Citrate and 150 mM NaCl pH 6.4  (Figure 
A.10).  
 
A.II.2.b Screening for detergents 
Based on the results from the buffer screening, it was decided to work with the buffer 
yielding the best peak separation and the smallest aggregation peak, namely 20 mM 
Citrate pH 6.4, 150 mM NaCl supplemented with 0.03 % DDM. 
In a next step, it was decided to screen for detergents suitable for the purification of 
YoijI. In a first approach different detergents were screened by solubilizing the 
protein YojI in DDM, a detergent known to be suitable for purification (Sennhauser 
2004). After protein binding onto the Ni-IMAC column, DDM was exchanged for 
eight different detergents during the subsequent washing steps (Table A.3). Further 
analysis revealed that the detergents DDM, Cymal-7, Fos-12 and UDM are suitable for 
the purification of YojI. 
 
Table A.3) Detergent screening for YojI. The protein was first solubilized in DDM which was 
exchanged for the tested detergent on the Ni-IMAC column.  
 
Detergent Ratio  between dimer peak and 
aggregation peak (peak height) on SEC 
Remarks 
Cymal-6 0.028 % 70:30  
Cymal-7, 0.01 % 70:30 Peak between aggregate and 
dimer 
Fos-16 0.00159 %  Precipitation 
Fos-14  0.014 % 80:20 Oligomerization peak 
Fos-12  0.15 % 60:40 Good peak separation 
LDAO 0.069 % 60:40 Oligomerization peak 
Thesit 2.7% 55:45 Poor peak separation 
UDM, 0.05 % 20:80 Protein prone to aggregation 
when concentrated 
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With this subset of detergents, the purification was performed by using the respective 
detergent already in the solubilization step (Table A.4).  
 
 Table A.4) Purification in different detergents. The protein was solubilized and purified in the same 
detergent. 
 
Detergent Ratio of Dimer peak and aggregation 
peak (peak height) in SEC 
Yield Remarks 
DDM, 0.03 % 60:40 1 mg / litre 
of culture 
 
Cymal-7, 0.01 % 70:30 0.5 mg / 
litre of 
culture 
Additional peak 
between aggregate 
and dimer 
Fos-12 0.15 % 60:40 1 mg / litre 
of culture 
 
UDM, 0.05 % 80:20 0.25-1 mg / 
litre of 
culture 
Protein prone to 
aggregation when 
concentrated 
 
The resulting size exclusion chromatogram and SDS-PAGE analysis are depicted in 
Figures A.13 and A.9. 
Previous studies showed that the protein YojI did not show a high stability in the 
detergent DDM (data not shown). However, the isolated dimer peak of Yoji exhibited 
a high degree in stability for the selected detergents UDM and Cymal 7, as seen by 
reinjecting the peak after a period of one week (Figure A.14). 
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Figure A.13) Purification and SEC analysis of YojI in the detergents UDM, Cymal7 and Fos-12. a) SEC 
chromatogram of the last purification step of YojI in UDM (red), Cymal 7 (green) and Fos-12 (blue). b)  
SDS-PAGE analysis of the fractions of the last peak of the different detergents (M=MW marker, Fos12= 
Foscholine 12, C7=Cymal7, UDM=UDM). 
 
a)      b) 
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Figure A.14) SEC of the purified protein YojI after 7 days incubation at 4°C in the different detergents. 
a) UDM, b) Cymal 7.  
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Unfortunately, no basal ATP hydrolysis activity could be measured with purified YojI. 
Moreover, no binding of the transporter to ATP-linked agarose resin could be detected. 
Nevertheless, it was decided to proceed with crystallization experiments. 
 
 
A.II.2.c Purification experiments of the ABC-transporter HlyB of E. coli 
 
The ABC-transporter HlyB of the E.coli strain CFT037, expressed in the E.coli strain 
BL21(DE3) was purified according to the established protocol (Sennhauser 2004). 
However, only a small amount of protein could be purified, because the majority of the 
protein aggregated on the Ni-IMAC resin during the washing steps (Figure A.15). Trials 
to improve the yield using different detergents (DDM, DM and LDAO) or purifying 
HlyB originating from the E.coli strain 536, expressed in the E. coli strain BL21(DE3) 
were unsuccessful.  
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Figure A.15) SDS-PAGE analyis of a purification attempt of HlyB of the E.coli strain 536 expressed in the 
E. coli strain BL21(DE3) in 20 mM Tris, 150 mM NaCl pH 7.5, 0.03% DDM M= MW marker, Samples 1-
6:  Stepwise elution (1ml fractions) from the IMAC column with elution buffer containing 250 mM 
imidazole, R= loaded IMAC resin. 
HlyB 
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A.II.3. Crystallization experiments of the ABC-transporter YojI 
Crystallization experiments of the protein YojI were done at various protein 
concentrations and buffer conditions, as listed in table 5. Prior of setting up the trials, 
the protein was fixed in different conformation, suitable for crystallization. The 
addition of ADP and vanadate, the ATP–analogue AMP-PNP and the cofactor MgCl2 
are known to arrest the NBD of the transporter in the different conformation states of 
the hydrolysis cycle. However, no crystals could be obtained. 
 
 
Table A.5) List of the crystallization trials of the protein YojI. The detergent, concentration, additions 
prior to crystal set ups, as well as the screens are indicated. 
  
Detergent Concentrations Additions prior to crystal set ups 
 
Screens 
Cymal 7 5-20 mg/ml MgCl2 
 
McKinnon 
Screens 1-6 
Cymal 7 5-20 mg/ml Na3VO4, ADP, MgCl2 McKinnon 
Screens 1-6 
Cymal 7 5-20 mg/ml ATP, MgCl2 McKinnon 
Screens 1-6 
DDM 10 mg/ml MgCl2 
 
McKinnon 
Screens 1-6 
DDM 10 mg/ml Na3VO4, ADP, MgCl2 
   
McKinnon 
Screens 1-6 
Fos-12 10 mg/ml  McKinnon 
Screens 1-6 
Fos-12 10 mg/ml MgCl2 McKinnon 
Screens 1-6 
Fos-12 10 mg/ml MgCl2, ATP 
 
McKinnon 
Screens 1-6 
Fos-12 10 mg/ml Na3VO4, ADP, MgCl2 
 
McKinnon 
Screens 1-6 
Fos-12 10 mg/ml ADP McKinnon 
Screens 1-6 
UDM 10 mg/ml MgCl2 McKinnon 
Screens 1-6 
UDM 10 mg/ml MgCl2, ATP 
 
McKinnon 
Screens 1-6 
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Detergent Concentrations Additions prior to crystal set ups 
 
Screens 
UDM 10 mg/ml Na3VO4, ADP, MgCl2 
 
McKinnon 
Screens 1-6 
DM 10 mg/ml MgCl2 McKinnon 
Screens 1-6 
DM 10 mg/ml MgCl2, ATP 
 
McKinnon 
Screens 1-6 
DM 10 mg/ml Na3VO4, ADP, MgCl2 
 
McKinnon 
Screens 1-6 
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A.II.4. Nucleotide Binding domains of the ABC-transporters YojI and 
HlyB 
 
The coding sequences of the NBD of the protein YojI and HlyB were successfully 
cloned and over-expressed using the vector pET21 with a C-terminal His-tag, as seen 
in Table A.6. 
 
Table A.6) Constructs used for characterization of the NBDs of ABC-transporters. The expression host, 
yield and activity are shown. 
 
Gene Vector Remark Expression host Expression 
condition 
Yield of 
purified 
protein 
Acitivty 
HlyB-
NBD 
(536) 
pET21 C-
terminal 
His6-tag 
E. coli  
BL21(DE3) 
 
Grown in LB, 
37°C 4h 
expression 
time 
3 mg/ 
200ml 
bacterial 
culture 
Not active 
YojI-NBD 
(CFT037) 
pET21 C-
terminal 
His6-tag 
E. coli  
BL21(DE3) 
 
Grown in LB, 
37°C 4h 
expression 
time 
3 mg/ 
200ml 
bacterial 
culture 
Not active, 
binding to 
ATP-
agarose 
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Figure A.16) Purification of the NBD of the transporter YojI. a) Size exclusion chromatogram depicts a 
monodisperse peak b) SDS-PAGE analysis of the peak fraction,as marked in panel a, that was used for 
crystallization experiments. M= MW marker, S= sample 
a)             b) 
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The NBD of the transporters could be easily purified using Ni-IMAC followed by SEC 
yielding about 3 mg out of 200 ml bacterial culture (Figure A.16). 
Unfortunately the NBD of YojI did not show any ATPase activity, but it could be 
bound to and eluted from ATP-linked agarose resin (Figure A.17). 
 
 
 
Crystallization experiments were done at varying protein concentrations and buffer 
formulations as enlisted in Table A.7. 
For the construct of the NBD of YojI, crystals were obtained in the two buffer 
conditions 0.1 M Tris pH 8, 0.15 M KSCN and 22 % PEG 3350 and Tris 0.1 M, pH 9 
PEG 3350 18%, KSCN 0.15 M CoCl2 in presence of Na3VO4, ADP, MgCl2. These 
crystals are shown in figure 18.  In both cases the crystals did not diffract when tested 
on the home source (CuKα radiation generated by a Nonius FR591 rotating anode 
generator). 
 
 
 
Figure A.17) Binding and elution of the Yoji NBD on ATP-linked agarose. M = marker, FT= flow-through, 
W = wash, 1 = elution 1, 2 = elution 2, the elution steps were done in presence of 20 mM ATP  
M       FT  W   1   2 
MW 
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25 
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Table A.7) List of the crystallization trials of the NBD of YojI. The concentration, additions prior 
crystal set ups, as well as the screens are indicated. 
 
Protein Concentrations Additions prior to crystal set 
ups 
Screens 
YojI-NBD 5-20 mg/ml MgCl2 
 
- Clear Strategy Screen™ I & 
II; pH 5.5, 6.5,7.5 and 8.5 
(Molecular Dimensions) 
- GS002 
- # 82009 Crystallization 
Basic Kit and #70437 
Crystallization Extension Kit 
(Sigma Fluka) 
YojI-NBD 5-20 mg/mlt Na3VO4, ADP, MgCl2 - Clear Strategy Screen™ I & 
II; pH 5.5, 6.5, 7.5, 8.5 
(Molecular Dimensions) 
- GS002 
- # 82009 Crystallization 
Basic Kit 
- # 70437 Crystallization 
Extension Kit (Sigma Fluka) 
YojI-NBD 5-20 mg/ml ATP, MgCl2 
 
- Clear Strategy Screen™ I & 
II; pH 5.5, 6.5, 7.5, 8.5 
(Molecular Dimensions) 
- GS002 
- # 82009 Crystallization 
Basic Kit (Sigma Fluka) 
- # 70437 Crystallization 
Extension Kit (Sigma Fluka) 
YojI-NBD 10 mg/ml MgCl2 
 
- GS041 
(18% PEG 3350, 0.1M Tris 
(HOAc), 0.15 M KSCN 
pH 8, pH 8.5, pH 9) 
YojI-NBD 10 mg/ml Na3VO4, ADP, MgCl2 
   
-GS041 
(18% PEG 3350, 0.1M Tris 
(HOAc), 0.15 M KSCN 
pH 8, pH 8.5, pH 9) 
 
 
Figure A.18) Crystals obtained of YojI-NBD a) in 0.1 M Tris pH 8, 0.15 M KSCN and 22 % PEG 3350 b) 
in 0.1 M Tris, pH 9, 18 % PEG 3350, 0.15 M KSCN and 0.01 M CoCl2. 
a)      b) 
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A.III Discussion 
 
The crystallization of integral membrane proteins, such as ABC-transporters, is 
known to be a challenging task. A multitude of members of a protein family have to 
be screened in order to obtain stable and pure material for crystallization. This work 
focussed on half transporters having the NBD fused to the TMD, simplifying the 
cloning and purification of the proteins. 
A purification protocol for the transporter YojI was established resulting in a stable 
protein that was used for crystallization experiments. Additionally, purification of the 
NBD of YojI yielded the protein in a monomeric state. 
 
Although straightforward cloning techniques were exploited, the cloning of some 
transporters failed, as it was the case for the gene mchF; and several transporters 
could not be expressed at a reasonable amount, as it was the case for the transporter 
MclB. The problem was most likely due to the high toxicity of these transporters to 
the bacterial cell (Pons, Delalande et al. 2004).  For the proteins that were expressing 
at detectable amounts, the expression level was dependent on the expression system 
and the expression conditions. For the proteins YojI and HlyB, the IPTG inducible 
vectors pET21/28 coding for a C-terminal His-tag were most suitable. 
 
One crucial step in the purification process is the solubilization of the protein from 
the membrane. Detergent molecules have to replace the lipids of the membrane and 
shield the hydrophobic part of the protein. Moreover, the buffer conditions, such as 
pH and the ionic strength, need to be properly determined in order to avoid 
aggregation or denaturation of the protein. Since the detergent impairs biophysical 
characterization, it is not always easy to determine the folding state of a membrane 
protein. In this study, we have optimized the buffer and detergent condition for YojI. 
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We succeeded to purifiy this transporter in four different detergents at yields that 
allowed for setting up crystallization trials. 
Although we obtained dimeric YojI as judged from SEC, no ATPase activity could be 
measured; therefore it is questionable, whether the protein YojI as purified here is in 
a functional state. The absent ATPase activity could be attributed to the lack of 
substrate addition, as the substrate (microcine J25) was unknown at the time the 
experiment was performed. For some ABC exporters such as the peptide tranporter TAP, 
the addition of the substrate is absolutely required to initiate ATP hydrolysis, i.e. ATP 
hydrolysis and substrate binding could also be tightly coupled in YojI (Chen, Abele et al. 
2003) . 
Future experiments could therefore include activity assays in the presence of the 
microcin J25 of YojI in either detergent solution, or reconstituted in a lipidic 
environment. Additionally, crystallization trials with the substrate microcin J25 could 
be performed. 
 
Biochemical information on the NBDs of ABC transporters can be of interest to 
understand the functional mechanism of the entire transporter. The NBD of the 
transporter YojI was purified and could be bound to ATP-linked agarose indicating 
proper folding. Protein crystals were obtained but turned out to be non-diffracting. 
Based on results from bioinformatic predictions (Figure A.18) and partial tryptic 
digests (not shown) a future construct excluding the flexible linker regions located 
between the TMD and NBD and part of the C-terminus, could lead to a more stable 
protein domain with a better chance to provide diffracting crystals.  
 
Based on the information obtained, screening further ABC transporter homologues 
for biochemical and biophysical characterization is worthwhile. In addition,  specific 
binding partners such as DARPins and single chain antibody fragments could be 
raised against ABC transporters that can be purified, in order to increase the chance 
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to obtain well diffracting crystals (Ostermeier, Iwata et al. 1995; Sennhauser, Amstutz 
et al. 2007).  
 
 
 
Figure A.18) Model of YojI-NBD, established by the software MODELLER in cartoon representation. 
The long unstructured N-terminus is clearly visible. 
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A.IV Material and Methods 
 
A.IV.1 Cloning of the ABC-transporter 
The plasmid encoding the ABC transporter mclB was a friendly gift of Sophie Sablé 
(Université La Rochelle, F). 
The genes mclB and mchF derived from E. coli were amplified by PCR and cloned in 
the vectors pET21-Nt-His-tag, pET21-Ct-His-tag and pBAD24-Ct-His-tag. These 
vectors were already known to be suitable for these transporters (Frey 2007).  
 
Cloning was done using PCR with primers for the desired protein, carrying the 
nucleotide sequence for the restriction site (BamHI and XhoI). The used primersare 
enlisted in Table A.8.  
 
Table A.8) Primers used for cloning of the ABC-transporters. 
Primer Sequence 
MchF_s1 TAGTCATGGATCCATGACTAACGGGAATTTCAGACAAATTATA 
MchF_s2 TATGGTCGGTATCCGGGGAAC 
MchF_as1 GTTCCCCGGATACCGACCATA 
MchF_as2 TAGTCATCTCGAGAATAGAAATAATCCTGTCAACAGTTCTCAACG 
MclB_as1 TAGTCATCTCGAGAATGGAAATAACTCTGTCAACAGTTTTCAAC 
MchE_as1 TAGTCATCTCGAGGTCATTGAGCGGTCCTGTTGCACTGTGTT 
MchE_pBAD_s GCTAGTATTACTATGAGCTCATGTTTCGCCAGGATG 
sp_hemo CGGGATCCATGGATTCTTGTCATAAAAT 
ap_hemo CCGCTCGAGGTCTGACTGTAACTGATA 
HlyBpBAD CGCAGACCATGGATTCTTGTCATAAAAT 
 
 
A.IV.2 Expression Tests 
Expression of the proteins in the cloned vectors were tested in different expression 
systems, the cell lines BL21(DE3), C41(DE3) and C43(DE3) (Miroux and Walker 
1996). For screening for the optimal expression conditions, pre-cultures of 
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transformed bacterial cells were used for inoculation of 5 ml liquid media. Bacterial 
cells were grown at 37 °C in the media LB or 2YT. Ampicillin and Kanamycin were 
used at a concentration of 0.1 mg/ml and 0.05 mg/ml, respectively. The protein over-
expression was induced at an OD600 of 0.6. Multiple expression temperatures and times 
were tested: 37°C 4h, 30°C 4h and 18°C 20h, The arabinose-inducible vector was 
induced with 0.2%, 0.02%, 0.002% L-arabinose, the IPTG-inducible vecors were 
induced with 0.05, 0.1, 1 and 5 mM IPTG. 
The overexpression was visualized by Dot Blot or Western Blot analysis, using 
antibodies specific to His-tagged protein (either a scFv ((Kaufmann, Lindner et al. 
2002)) or commercial antibody (Quiagen)).  
A.IV.3 Expression and Purification of the ABC-transporters 
The full length transporter YojI and HlyB were expressed in shaking flasks with 500 
ml of liquid media 2YT for protein purification. After induction with 0.1 mM IPTG 
the proteins were expressed at 18°C for 16 h. 
After expression, cells were pelleted down and stored at -80°C for purification. 
After thowing of the frozen pellets, the cells resuspended in 25 ml lysis buffer (20 mM 
Tris, 150 mM NaCl pH 7.5, DNAse and Complete Protease Inhibitor (Roche)) per 
pellet of 1 l bacterial culture and lysed using by French Pressing  
The cellular debris was separated from the lysate with centrifugation at 5000 g for 15 
min. Subsequently the membrane fraction was spun down by ultracentrifugation at 
45 000 rpm for 1 h. The protein was solubilized in 30 ml of detergent-enriched buffer 
(20 mM Tris, 150 mM NaCl pH 7.5, respective detergent) per pellet.  For the 
solubilization the detergents were used at the following concentrations: 1% DDM, 1 
% Cymal 7, 2 % UDM and 5% Fos-12. During the purification, DDM was used at 0.03 
%, Cymal 7 at 0.03 %, UDM at 0.1% and Fos-12 at 0.15%. 
The non-solubilized material was spun down by a second ultracentrifugation step, 
before subjecting it to a pre-equilibrated Ni-NTA-IMAC column (Pharmacia). 
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Washing steps were performed with increasing imidazole concentrations via a 2-step 
gradient with 20 and 50 mM respectively.  The protein was eluted in presence of high 
imidazole (250mM) and concentrated in a centricon (Millipore) concentrator with a 
molecular weight cut off of 100 kDa. 
Size-exclusion chromatography was used in the buffer 20 mM Tris, 150 mM NaCl pH 
7.5 or 20 mM Citrate, 150 mM NaCl, pH 6.5 for the final purification step and 
subsequently the samples were analysed by SDS-PAGE. 
 
A.IV.4 Cloning, expression and purification of the NBDs 
The NBD of the protein YojI was cloned using the restriction sites EcoRI and XhoI in 
the vector pET21-C-terminal His-tag. The used primers are enlisted in Table9. The 
NBD of the protein YojI was expressed in 2 x 100 ml of LB media for protein 
purification at 37°C for 4h after induction with 1mM of IPTG. 
The cell pellet containing the YojI-NBD was lysed using a French Press using 20 ml of 
lysis buffer containing 20 mM Tris, 150 mM NaCl pH 7.5 and DNAse. The lysate was 
filtered with a pore size of 0.2 μm and subjected to a Ni-Protino column (Macherey & 
Nagel). Washing was done with 20 ml of Wash Buffer (20 mM Tris, 150 mM NaCl pH 
7.5) and eluted with elution buffer (20 mM Tris, 150 mM NaCl pH 7.5, 250 mM 
imidazole). All purification steps were done at 4°C.  
 
Table A.9) Primers used for the cloning of the NDBs of the ABC-transporters HlyB and YojI. 
Primer Sequence 
HlyBNBD GCCGGATCCGATATCTTTCGT 
YojI_NBD_s GCTATGAATTCACGGCGCAGGTGGC 
 
A.IV.5 Screen on buffers and detergents 
In order to screen for optimal purification conditions, different buffers and detergents 
were used. The protein was purified in 20 mM of the corresponding buffer, while the 
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NaCl was kept constant at 150 mM, the detergent was used at concentrations of 100X 
CMC for solubilization and 3X CMC for purification. 
The following non-ionic detergents containing maltosides as uncharged, hydrophilic 
head groups were used: n-Dodecyl-β-Maltopyranoside (DDM) n-Undecyl-β-
Maltopyranoside (UDM), n-Decyl-β-Maltopyranoside (DM) and n-Octyl-β-
Maltopyranoside (OM). As non-ionic detergents containing glucosides as uncharged, 
hydrophobic head groups were used: n-Octyl-β-Glucopyranoside (OG), n-octyl-β-D-
thioglucopyranoside (OTG). As lipid-like detergents n-Dodecylphosphocholine (Fos 
12), n-Tetradecylphosphocholine (Fos 14), n-Hexadecylphosphocholine (Fos 16). 
Furthermore the cyclo-alkyl detergents 7-Cyclohexyl-1-hexyl-β-D-maltoside (Cymal 
7), 6-Cyclohexyl-1-hexyl-β-D-maltoside (Cymal 6) were tested. As zwitterionic 
detergents N,N-Dimethyldodecylamine-N-oxide (LDAO),  N,N-Dimethyldecylamine-
N-oxide (DDAO) and 3-[(3-Cholamidopropyl)-dimethylammino]-1-propanesulfonate 
(CHAPS) were used. The protein YojI was first solubilized in DDM, subsequently the 
detergent was exchanged on the Ni-NTA column during the subsequent washing 
steps. 
A.IV.6 Activity assays 
The activity of the proteins was determined by detecting the quantity of phosphate 
liberated via formation of Malachite green – phosphomolybdate complex as decribed 
(Van Veldhoven and Mannaerts 1987). A standard curve was determined using a 
dilution series of H3PO4. 
Binding assays were performed using ATP agarose (Sigma-Aldrich) in presence of 1 
mM MgCl2 by rotation at 4°C for 2h. The sample was washed 2 times using 20 mM 
Tris, 150 mM NaCl, pH 7.5 and eluted in presence of 20 mM ATP. For the full length 
transporter the buffers were supplemented with 0.03% DDM. 
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A.IV.7 Crystallization experiments 
All crystallization experiments were done by sitting drop with vapour diffusion 
against a reservoir of varying buffer conditions. Different crystallization screens based 
on different buffer compositions were done at the NCCR crystallization facility at 4°C 
and 20°C. The crystal screens used are listed in the appendix. 
 
 
 
 
 
Biophysical characterization of SGT1  Introduction 
 44 
A.V Literature 
 
Azpiroz, M. F., E. Rodriguez, et al. (2001). "The structure, function, and origin of the 
microcin H47 ATP-binding cassette exporter indicate its relatedness to that of 
colicin V." Antimicrob Agents Chemother 45(3): 969-72. 
Blond, A., M. Cheminant, et al. (2001). "Solution structure of microcin J25, the single 
macrocyclic antimicrobial peptide from Escherichia coli." Eur J Biochem 268(7): 
2124-33. 
Borbat, P. P., K. Surendhran, et al. (2007). "Conformational motion of the ABC 
transporter MsbA induced by ATP hydrolysis." PLoS Biol 5(10): e271. 
Chen, M., R. Abele, et al. (2003). "Peptides induce ATP hydrolysis at both subunits of 
the transporter associated with antigen processing." J Biol Chem 278(32): 29686-
92. 
Dawson, R. J. and K. P. Locher (2006). "Structure of a bacterial multidrug ABC 
transporter." Nature 443(7108): 180-5. 
Dean, M. and R. Allikmets (1995). "Evolution of ATP-binding cassette transporter 
genes." Curr Opin Genet Dev 5(6): 779-85. 
Dean, M., A. Rzhetsky, et al. (2001). "The human ATP-binding cassette (ABC) 
transporter superfamily." Genome Res 11(7): 1156-66. 
Delgado, M. A., P. A. Vincent, et al. (2005). "YojI of Escherichia coli functions as a 
microcin J25 efflux pump." J Bacteriol 187(10): 3465-70. 
Frey, D. (2007). Biochemical and Structural Studies of Dimethylarginine 
Dimethylaminohydrolase-1, the ABC Transporter Superfamily and the Sodium 
Citrate Transporter CitS. MNF Zurich, University of Zurich. PhD: 204. 
Havarstein, L. S., D. B. Diep, et al. (1995). "A family of bacteriocin ABC transporters 
carry out proteolytic processing of their substrates concomitant with export." Mol 
Microbiol 16(2): 229-40. 
Higgins, C. (1992). "ABC transporters: from microorganisms to man." Annu Rev Cell 
Biol 8: 67-113. 
Biophysical characterization of SGT1  Introduction 
 45 
Higgins, C. F. and K. J. Linton (2004). "The ATP switch model for ABC transporters." 
Nat Struct Mol Biol 11(10): 918-26. 
Holland, I. B. and M. A. Blight (1999). "ABC-ATPases, adaptable energy generators 
fuelling transmembrane movement of a variety of molecules in organisms from 
bacteria to humans." J Mol Biol 293(2): 381-99. 
Hopfner, K. P., A. Karcher, et al. (2000). "Structural biology of Rad50 ATPase: ATP-
driven conformational control in DNA double-strand break repair and the ABC-
ATPase superfamily." Cell 101(7): 789-800. 
Hwang, J., X. Zhong, et al. (1997). "Interactions of dedicated export membrane proteins 
of the colicin V secretion system: CvaA, a member of the membrane fusion 
protein family, interacts with CvaB and TolC." J Bacteriol 179(20): 6264-70. 
Kaufmann, M., P. Lindner, et al. (2002). "Crystal structure of the anti-His tag antibody 
3D5 single-chain fragment complexed to its antigen." J Mol Biol 318(1): 135-47. 
Kobayashi, N., K. Nishino, et al. (2001). "Novel macrolide-specific ABC-type efflux 
transporter in Escherichia coli." J Bacteriol 183(19): 5639-44. 
Locher, K. P. (2009). "Review. Structure and mechanism of ATP-binding cassette 
transporters." Philos Trans R Soc Lond B Biol Sci 364(1514): 239-45. 
Locher, K. P., A. T. Lee, et al. (2002). "The E. coli BtuCD structure: a framework for 
ABC transporter architecture and mechanism." Science 296(5570): 1091-8. 
Miroux, B. and J. E. Walker (1996). "Over-production of proteins in Escherichia coli: 
mutant hosts that allow synthesis of some membrane proteins and globular 
proteins at high levels." J Mol Biol 260(3): 289-98. 
Muller, K. M., C. Ebensperger, et al. (1994). "Nucleotide binding to the hydrophilic C-
terminal domain of the transporter associated with antigen processing (TAP)." J 
Biol Chem 269(19): 14032-7. 
Oldham, M. L., D. Khare, et al. (2007). "Crystal structure of a catalytic intermediate of 
the maltose transporter." Nature 450(7169): 515-21. 
Ostermeier, C., S. Iwata, et al. (1995). "Fv fragment-mediated crystallization of the 
membrane protein bacterial cytochrome c oxidase." Nat Struct Biol 2(10): 842-6. 
Pons, A. M., F. Delalande, et al. (2004). "Genetic analysis and complete primary 
structure of microcin L." Antimicrob Agents Chemother 48(2): 505-13. 
Biophysical characterization of SGT1  Introduction 
 46 
Pons, A. M., I. Lanneluc, et al. (2002). "New developments in non-post translationally 
modified microcins." Biochimie 84(5-6): 531-7. 
Quinton, P. M. (1999). "Physiological basis of cystic fibrosis: a historical perspective." 
Physiol Rev 79(1 Suppl): S3-S22. 
Rees, D. C., E. Johnson, et al. (2009). "ABC transporters: the power to change." Nat Rev 
Mol Cell Biol 10(3): 218-27. 
Rosenberg, M. F., R. Callaghan, et al. (1997). "Structure of the multidrug resistance P-
glycoprotein to 2.5 nm resolution determined by electron microscopy and image 
analysis." J Biol Chem 272(16): 10685-94. 
Sauna, Z. E. and S. V. Ambudkar (2007). "About a switch: how P-glycoprotein (ABCB1) 
harnesses the energy of ATP binding and hydrolysis to do mechanical work." Mol 
Cancer Ther 6(1): 13-23. 
Seeger, M. A. and H. W. van Veen (2009). "Molecular basis of multidrug transport by 
ABC transporters." Biochim Biophys Acta 1794(5): 725-37. 
Sennhauser, G. (2004). Expression and purification of an ABC transporter. Biochemische 
Insitut. Zuerich, University of Zuerich. Diplom. 
Sennhauser, G., P. Amstutz, et al. (2007). "Drug export pathway of multidrug exporter 
AcrB revealed by DARPin inhibitors." PLoS Biol 5(1): e7. 
Story, R. M. and T. A. Steitz (1992). "Structure of the recA protein-ADP complex." 
Nature 355(6358): 374-6. 
Urbatsch, I. L., B. Sankaran, et al. (1995). "Both P-glycoprotein nucleotide-binding sites 
are catalytically active." J Biol Chem 270(45): 26956-61. 
Van Veldhoven, P. P. and G. P. Mannaerts (1987). "Inorganic and organic phosphate 
measurements in the nanomolar range." Anal Biochem 161(1): 45-8. 
Vincent, P. A. and R. D. Morero (2009). "The structure and biological aspects of peptide 
antibiotic microcin J25." Curr Med Chem 16(5): 538-49. 
Walker, J. E., M. Saraste, et al. (1982). "Distantly related sequences in the alpha- and 
beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring 
enzymes and a common nucleotide binding fold." Embo J 1(8): 945-51. 
Ward, A., C. L. Reyes, et al. (2007). "Flexibility in the ABC transporter MsbA: 
Alternating access with a twist." Proc Natl Acad Sci U S A 104(48): 19005-10.
Biophysical characterization of SGT1  Introduction 
 47 
 
 
Chapter B -Biophysical characterization of SGT1 
 
B.I Introduction 
B.I.1 Inflammation and innate immunity 
The word “inflammation” originates from the Latin word “inflammare”, meaning “to 
set on fire”. Inflammation in an affected area is generally characterized by five clinical 
signs: redness and increase of temperature, swelling, loss of function and pain. These 
macroscopic observations are a result of a set of reactions in the mammalian immune 
system that are triggered in response to foreign objects in the body, such as bacteria, 
viruses but also in response to small molecules such as ATP.  
In inflammatory processes, immune cells are recruited to the site of inflammation, 
pathogens are removed by macrophages and neutrophils, and the adaptative immune 
system and the complement cascade are activated.   
The inflammasome plays a central role for this multitude of reactions (Martinon, 
Burns et al. 2002). 
A hallmark during the inflammatory reaction is the formation of the NLRP3 
(NACHT-, LRR- & Pyrin-domain containing) inflammasome, which activates the 
inflammatory caspase-1 (Martinon, Petrilli et al. 2006). Activated caspase-1 then 
processes the mediators of the inflammatory response, e.g. IL-1β (Martinon, Burns et 
al. 2002). The protein SGT1, the focus of this project, plays an important role in the 
formation of the inflammasome. 
B.I.2 The inflammatory cascade 
Inflammatory cascades are initiated by pathogen-recognition receptors (PRRs) that 
recognize pathogen-associated molecular patterns (PAMPs) thereby triggering a 
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response to the microbial and endogenous stimuli. PAMPs can be lipopolysaccharides 
(LPS) or peptidoglycans (PGNs) derived from the degradation of bacterial cell wall, 
viral DNA, but also ATP, DNA, RNA and uric acid.  
The PRRs can be divided into two groups; the Toll-like receptors (TLRs), 
which are transmembrane receptors sensing the inflammatory stimuli already outside 
the cell, and the nucleotide binding domain, leucine rich repeat containing  receptors 
(NLRs), which are intracellular receptors. They are responsible for the pathogen 
recognition inside the cell. Both, TLRs and NLRs are constituted of several domains 
and are binding to host-derived molecules. Their common domain is the leucine rich 
repeat (LRR) domain, responsible for the detection of the pathogen.  
The family of NLRs comprises the NLRA (member: CIITA class II, major 
histocompatibility complex, transactivator), NLRPs (NLR family, pyrin domain 
containing proteins), the NLRB (member: NAIP NLR family, apoptosis inhibitory 
protein), the, NLRX (NOD-like receptor with “unknown” domain, members NOD1&2 
nucleotide-binding oligomerization domain containing) and NLRC (NLR forming, 
CARD domain containing). Next to the C-terminal LRR-domain, all NLRs share also a 
NACHT domain (domain present in NAIP, CIITA, HET-E and TP1) (Koonin and 
Aravind 2000), which was proposed to be a switch for conformational changes and 
has an ATPase activity. It is also responsible for the oligomerization of NLRs.  
The N-terminal recruitment domain of NLRs is variable and can be a CARD 
(caspase recruitment domain), BIR (Baculoviral inhibitor of apoptosis Repeats), PYD 
(pyrin) or a transmembrane domain (Ye and Ting 2008). These domains are 
responsible for inter-protein interactions and confer specificity. Different stimuli 
activate the NLRs, NLRP3, NOD1 and NOD2 for example are activated by 
mesodiamiopimelic acid and muramyl dipeptide, the degradation products of PGN, 
(Martinon, Agostini et al. 2004; Fritz, Ferrero et al. 2006). 
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Different stimuli activate the NLRs, which in turn activate different 
inflammasomes and different responses. 
NLRP3, NOD1 and NOD2 for example are activated by meso-diaminopimelic 
acid and muranyldipeptide (MDP), both degradation products of PGNs. Upon 
activation, NOD2 forms a complex with RIP2 (receptor interacting kinase 2) that 
activates NF-κB and Pro-IL-1β synthesis (Meylan and Tschopp 2005). NLRP3 
activation induces inflammasome formation, which activates caspase-1 that processes 
ProIL-1β to functional IL-1β (Figure B.1). 
 
The inflammatory response is highly regulated by pro- and anti-inflammatory 
cytokines. A deregulation might lead to immunodeficiency or auto-inflammatory 
diseases  (Alheim and Bartfai 1998). Also mutations in the inflammatory proteins can 
lead to diseases. Some well-studied examples are mutations in NLRP3, which lead to 
familial-cold auto-inflammatory syndrome Muckle-Wells syndrome (Aganna, 
Martinon et al. 2002; Dode, Le Du et al. 2002).  
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Figure B.1) Model for the activation of the inflammasome by PGN derivates  from (Martinon and 
Tschopp 2005). After phagocytosis of bacteria, MDP, the degradation product of PGN activates NOD2. 
A NOD2-RIP2 complex is formed. The resulting RIP2 activation leads to NF-κB activation. ProIL-1β is 
synthesized. The release of MDP also triggers the activation of NLRP3. The inflammasome complex 
(NLR3, cardinal, ASC and caspase-1) is assembled and activates caspase-1. ProIL-1β is then converted 
to IL-1β.   
 
B.I.3 The inflammasomes 
Three types of inflammasomes have so far been described: the NLRP1, NLRP3 and the 
NLRP4 inflammasomes (Figure B.2) (Martinon, Gaide et al. 2007). NLRP1 and NLRP3 
serve as the scaffolding proteins for these multi protein assemblies.  
NLRP3 interacts with the adaptor protein ASC (apoptosis-associated speck-like 
protein) which is comprised of a CARD and a PYD, via PYD-PYD interaction. ASC is 
then linked with the help of CARD-CARD interactions to caspase-1. The NLRP1 
inflammasome has a similar architecture, ASC links NLRP1 to caspase-1 and caspase-5 
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(Martinon, Burns et al. 2002; Agostini, Martinon et al. 2004). In the NLRP4 
inflammasome, no adaptor protein has been found. NLRP4 interacts directly with 
caspase-1 via the CARD domain (Poyet, Srinivasula et al. 2001). 
Caspases that bind to the inflammasomes are activated and are ready to process 
cytokines such as proIL-1β to its active form IL-1β, which is the main signalling 
molecule in the inflammatory response. 
 
B.I.4 Inflammatory caspases 
Inflammatory caspases are activated in the innate immune response as described 
above (Martinon and Tschopp 2004). They belong to the familiy of caspases, which 
are endopeptidases. This protein family is named after their catalytic residue, 
cysteine, involved in cleaving peptide bonds C-terminal from aspartate. 
Human inflammatory caspases are caspase-1, -4, -5 and -12. They are constituted of a 
pro-domain with a caspase-recruitment domain (CARD) followed by a catalytic 
domain.  
Caspase-1 (interleukin-1β converting enzyme, ICE) was the first caspase to be 
identified; it activates the inflammatory ProIL-1β to its mature active form IL-1β.  
Little is known with respects to the inflammatory pathways of caspases-4, -5 and -12. 
Caspase-5 is known to cleave caspase-3 (Schwartz, Yamamoto et al. 1999) and to 
process the transcription factor Max in vitro (Krippner-Heidenreich, Talanian et al. 
2001). Caspase-5 together with caspase-1 were found to be components of the NLRP1 
inflammasome, a complex involved in their reviewed by (Martinon, Burns et al. 
2002).  
For caspase-4 and caspase-12 it has been show, that they are involved in the so called 
endoplasmatic stress response (Nadiri, Wolinski et al. 2006); a mechanism acting 
against the viral infection by inducing protein overproduction and aggregation.  
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Figure B.2) Schematic overview of the interactions mediated by the scaffolding proteins of the NLR 
family for creating the different inflammasones (NLRC4-, NLRP1- and NLRP3-inflammasome, 
respectively). The oligomerization is initiated by the LRRs of NLRC4, NLRP1 and NLRP3 after binding 
to a ligand. The protein-protein interactions are mediated by homotypic domain dimerization. The 
scaffolding protein interacts with the inflammatory caspases either via a scaffolding protein or directly 
via the recruitment domain. The activated caspase is then processing the cytokine proIL-1β to IL-1β, 
starting the inflammatory response. Picture modified after (Martinon and Tschopp 2007). 
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B.I.5 The role of SGT1 in inflammation 
For the recruitment of NLRP3 to the inflammasome, HSP90 (Heat shock protein 90) 
and SGT1 are important. HSP90 is a chaperone well-known for being involved in 
protein folding and cell signalling (Lee, Jacob et al. 2004). SGT1 is a co-chaperone and 
“client adaptor”. It recruits specific clients to the HSP90 co-chaperone complex 
(Mayor A. et al (2007)). 
   
In the absence of HSP90 NLRP3 is unstable and is degraded by the proteasome. 
There is a possibilty that unbound NLRP3 might even autoactivate resulting in 
inflammasome formation. Binding of NLRP3 to HSP90 and SGT1 is observed and 
interpreted as stabilization and inactivation of NLRP3. Upon activation, SGT1 and 
HSP90 are released and NLRP3 adopts an alternative conformation, allowing it to 
interact with other inflammasome components, as depicted in Figure B.3 (Mayor, 
Martinon et al. 2007). 
 
The activation mechanism of other members of the NLR family is unknown, 
but it is presumed to be similar (Mayor, Martinon et al. 2007). Additionally, it has 
been shown, that SGT1 is also involved in the pathways mediated by NOD1, NOD2, 
NLR1-4, IPAF and NAIP (da Silva Correia, Miranda et al. 2007; Mayor, Martinon et 
al. 2007). 
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Figure B.3) Proposed model for SGT1 acting as a cochaperone for HSP90 in the inflammatory response 
after Mayor et al (2007). SGT1 and HSP90 are keeping NLRP3 in an active, but signalling competent 
state. As soon as a ligand is bound to the LRR, NLRP3 multimerizes and the other inflammasome 
components are recruited. NLRP3 alone is supposed to be instable and degraded by the proteasome. 
Picture modified after (Mayor, Martinon et al. 2007). 
 
B.I.6 SGT1 - function and its architecture 
TPR VR1 CS                  VR2        SGS
 
Figure B.4) The architecture of the human protein SGT1. This protein is constituted of the TPR 
domain, the CS domain and the SGS domain. The TPR domain is involved in oligomeric assembly and 
binding to skp1 during mitosis, the CS domain mediates the binding to HSP90 & RAR1 and the SGS 
domain binds to calcyclin and other S100 proteins. These domains are linked by variable regions (VR 1 
& 2). 
 
 
SGT1 is a highly conserved eukaryotic (Shirasu and Schulze-Lefert 2003). Along with 
its function in the mammalian immune system (Mayor, Martinon et al. 2007), and the 
hypersensitivity response in plants, it is also involved in cell cycle regulation, where it 
has been first discovered in yeast. It was subsequently named SGT1, which stands for 
suppressor of the G2 allele of skp1. It has been shown that the two proteins, SGT1 as 
Biophysical characterization of SGT1  Introduction 
 55 
well as skp1 are required for the G1/S and G2/M transition in the cell cycle (Kitagawa, 
Skowyra et al. 1999). 
 
Figure B.5) Sequence alignment of SGT1 from different organism. Sc= Saccharomyces cerevisiae, 
Hs=human, Hv= barley, Os=rice, At= Arabidopsis thaliana. The coloring indicates the level amino acid 
identity or similarity: black= 100%,dark grey = 80%, light grey = 60 %; taken from (Azevedo, 
Sadanandom et al. 2002). 
 
In human, two isoforms of SGT1 are found, which differ in 33 amino acids in the TPR 
domain. The function and the architecture are the same. SGT1 consists of three 
domains, as depicted in Figure B.4. The tetratrico peptide repeat (TPR) domain is 
located at the N-terminus, followed by a central CS domain (CHORD and SGT1 motif 
or also called p23-like domain) and at a C-terminal a SGT1 specific (SGS) domain. 
Variable regions (VR1 and VR2) are found between these domains, when comparing 
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sequences of different species (Figure B.5). NMR experiments showed that these parts 
of the protein have no defined structure (Lee, Jacob et al. 2004).  
Homologous of human SGT1 have been found in many species. Most of them share 
this three domain architecture, but in the nematodes Caenorhabditis and Brugia the 
protein SGT1 just comprises two domains, the CS-domain and the SGS-domain 
(reviewed by (Shirasu 2008).  
 
Structural information of SGT1 of individual domains is available. 
The TPR domain is a protein-protein interaction domain, which is binding to skp1 in 
kinetochore assembly during mitosis (Catlett and Kaplan 2006). Besides, recent 
studies have shown that the TPR domain is mainly responsible for the stability of the 
SGT1 protein in plants, probably by forming oligomers  (Azevedo, Betsuyaku et al. 
2006; Nyarko, Mosbahi et al. 2007). X-ray structures of different TPR domains have 
been determined (Main, Xiong et al. 2003). They show a mainly alpha helical 
architecture. 
 
The CS domain plays a central role in plant disease resistance. Two binding sites 
located on opposite sites of the domains allow the simultaneous interactions with 
RAR1 and the N-terminal domain of HSP90 (Boter, Amigues et al. 2007). whereas 
RAR1 shares with the CS domain partially the same binding site on HSP90 (Kadota, 
Amigues et al. 2008). Although RAR1 is dispensable in disease resistance, it enhances 
the function of SGT1 on HSP90, which is then able to act as a recruiter for chaperone 
activities on multiprotein complexes (Boter, Amigues et al. 2007). The NMR structure 
of the CS domain of human SGT1, showed that the domain adopts a 2 x 2 and 1 x 3 
antiparallel ß-strand architecture (Lee, Jacob et al. 2004)). The topology is related to 
the one of the protein p23, which also shares high sequence homology with the CS 
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domain and also interacts with the N-terminal domain of HSP90 (Ali, Roe et al. 2006) 
(Figure B.6). 
In mammalian immune response, the precise interactions are still not determined. So 
far it is only known that the presence of the CS and SGS domain of SGT1 is essential 
for the interaction of NLRP3 to HSP90 (Mayor, Martinon et al. 2007). 
 
Recently, the crystal structure of the complex formed between the N-terminus of 
Hsp90 from Hordeum vulgare (70 % identical to human) and the CS domain of Sgt1a 
from Arabidopsis thaliana (36 % identical to human) shows how SGT1 interacts with 
HSP90 (Figure B.6).  
Most of the interacting residues of the CS domain are located on the surface of the 
four stranded β-sheet. This explains the binding of this domain to HSP90 in absence 
of ATP, conformational changes of HSP90 during the ATPase cycle exacerbate the 
binding (Boter, Amigues et al. 2007; Kadota, Amigues et al. 2008; Zhang, Boter et al. 
2008). 
c)
 
Figure B.6) X-ray structure of the CS domain of SGT1 of Arabidopsis thaliana and the N-terminal 
domain of Hordeum vulgare HSP90 (2JKI.pdb). The interactions are mediated by the 2x2 stranded β-
sheet. The colour coding is analogous to a), for HSP90 α-helices are coloured in red, β-sheets are 
coloured in yellow. 
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The human SGS domain can interact with calcyclin and other S100 proteins in a 
calcium specific manner (Nowotny, Spiechowicz et al. 2003). Currently its purpose in 
the pathogen response reaction is unknown, but it is assumed that it serves as an 
interaction domain for some LRR- containing proteins, like Mla1 from plant and 
NOD1 from mammals (Dubacq, Guerois et al. 2002; Bieri, Mauch et al. 2004; da Silva 
Correia, Miranda et al. 2007). NMR and CD spectroscopy studies of the SGS domain 
indicated that it is not a well folded globular domain having only a limited degree of 
α-helical secondary structure. 
 
B.I.7 Short summary of Results 
In this part of the PhD thesis the expression, purification and biophysical 
characterization of the human SGT1 protein is described. The obtained results will 
help in future attemps to characterize hSGT1 structurally and functionally. 
 
Different constructs of human SGT1 and its domains were designed. The oligomeric 
state of full length SGT1 and constructs comprising the first domains thereof (TPR-
CSD1-257 and TPR-CST14-235) were analysed by multi angle light scattering in the absence 
of cofactors or binding partners. 
To estimate the content of secondary structure, circular dichroism spectra were 
recorded. They revealed that SGT1 has characteristics of a highly alpha helical 
protein, presumably mediated by the TPR domain, as indicated by the spectra of TPR-
CSD1-257 and TPR-CST14-235. 
Fluorimetrical studies by recording spectra in presence and in absence of an 
denaturing agent, showed two different states for the full length SGT1 folding, 
whereas no clear discrimination of folding states for the SGS domain was detected. 
Indeed, 1D NMR spectroscopy confirmed that the SGS domain does not show any 
secondary structure.  
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Crystallization experiments of the full length protein SGT1 and on the constructs 
comprising the first two domains TPR-CST14-235 and TPR-CSD1-257, were performed. 
Although, both Thermofluor-based high-throughput buffer formula optimization, 
and hand set precipitation screens were used to optimize the crystallization 
conditions, no diffracting crystals were obtained. 
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B.II Results of SGT1: 
B.II.1 Constructs for biophysical characterization and crystallization trials 
Four constructs of the human protein SGT1b (NM_006704), one of the two isoforms 
found in humans, were used for the subsequent work: the full length SGT1, the SGS 
domain, TPR-CSD1-257 and TPR-CST14-235 were expressed as GST fusion proteins, depicted in 
Figure B.7. The constructs TPR-CSD1-257 and TPR-CST14-235 comprised the TPR and CS 
domains only and were determined by limited proteolysis from the full length protein, as 
described later.  
 
                                      
Figure B.7) The constructs of SGT1 and its domains used in this PhD thesis. The full length construct 
comprises amino acids 1-333 and the SGS domain the amino acids 230-333.  The constructs determined by 
degradation experiments TPR-CS14-235 and TPR-CS1-257 comprise the TPR and the CS-domain only. 
 
B.II.2 Expression and Purification of SGT1 and its domain SGS 
Optimal expression was observed for the fusion protein GST-SGT1 and for the fusion 
protein GST-SGS at 37°C for 4 h after induction in LB media. 
The full length protein SGT1 was co-purified with cleavage products after ion exchange 
chromatography, as seen in Figure B.8 a and b and confirmed by previous mass 
spectrometric analysis by G. Hausammann, revealing degradation products with 
molecular weights of 38.6 kDa, 35.6 kDa, 32.2 kDa and 25.7 kDa determined by mass 
spectroscopy (MALDI) (Hausammann 2007). In contrast to this, no degradation products  
 
 
SGT1 
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TPR-CS1-257 
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Figure B.8) Ion exchange chromatography and SDS-PAGE analysis of the different constructs of SGT1   a) 
Profile of the cation-exchange chromatography of SGT1 with a gradient of NaCl from 0 to 250 mM; b) SDS-
PAGE analysis of the peak fractions, as marked in a); M= Molecular weight marker. c) Elution profile of 
anion-exchange chromatography of the SGS domain of SGT1. d) SDS-PAGE analysis of the peak fractions; 
M= Molecular weight marker,as marked in c). 
  
were occurring when purifing the SGS domain alone, as seen in SDS-PAGE 
electrophoresis of the fractions eluted from ion exchange chromatography . 
 (Figure B.8 a-d). ESI-MS confirmed the identity of the protein by measuring a MW of 
38.6 kDa for the full length construct SGT1 and 12.6 kDa for the construct SGS. 
 
B.II.3 Determination of stable fragments 
It is known from the literature that purified SGT1 is prone to degradation (Catlett and 
Kaplan 2006). Successful crystallization of the full length construct could be impeded by 
this behaviour. Limited proteolysis experiments were carried out for the design of new 
constructs being resistant to degradation. Subsequently these constructs were cloned; they 
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contained the first two domains the TPR and the CS domain. These constructs were 
named TPR-CS1-257 and TPR-CS14-235. The limited proteolysis experiments were performed 
using two different approaches. In the first one, the degradation of the protein was 
observed at room temperature during a time course of 10 days. The SDS-PAGE already 
revealed a stable fragment with a molecular weight between 25-30 kDa, as seen in Figure 
B.9a. ESI-MS in collaboration with Dr. S. Chesnov (FGCZ) subsequently identified this 
most stable fragment, having a mass of 29096.2 Da. As calculated with the program 
GPMAW (Peri, Steen et al. 2001), this molecular weight refers to an N-terminal 
degradation product, being composed of the TPR and the CS domain only and comprises 
the amino acids 1-257. It matches the prediction by the sequence aligment and domain 
assignment from Azevedo and coworkers (Azevedo, Sadanandom et al. 2002), showing 
that this fragment lacks the SGS domain. 
 
a) b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.9) a) Determination of proteolysis resistant constructs, by keeping the protein SGT1 for 10 days at 
room temperature. SDS-PAGE analysis of the protein directly, (0) after 4 and after 10 days. M= Molecular 
weight marker. b) Determination of stable constructs by partial tryptic digest. SGT1 was incubated with 
trypsin, the reaction was stopped after 30, 45, 60 and 75 minutes by precipitation with TCA. M= Molecular 
weight marker. 
 
 
    M         0         4        10 days 
50 
40 
30 
25 
20 
 
15 
 
 
10 
 
0     30     45     60     75   min 
MW 
[kDa] 
MW 
[kDa] 
Stable 
fragment 
Biophysical Characterization of SGT1  Results 
 
 63 
The subsequently cloned construct TPR-CS1-257 includes amino acids 1- 257, having a 
theoretical molecular weight of 29095.8 Da (determined by protparam), without 
respecting the additional amino acids being introduced by the expression system.  
 
The second approach was to use a limited tryptic digestion for the determination of the 
stable protein boundaries. Two main fragments were obtained (Figure B.9b). The protein 
SGT1 was incubated with trypsin and the proteolysis reaction was stopped by TCA 
precipitation at different time points. MALDI analysis revealed two degradation products 
with masses of 25342.0 and 28420.0 Da. Additionally N-terminal sequencing in 
colaboration with Dr. R. Brunisholz (FGCZ) identified one stable fragment starting from 
the amino acid 14 to 235. Only this fragment was consistent with the N-terminal 
sequence and the mass. The subsequently cloned construct was named TPR-CS14-235, 
having a theoretical molecular weight of 25320 Da (determined by protparam), which is 
in the error range of the method (MALDI). The C-terminal end of the fragment is located 
after the CS domain, in the beginning of the variable region 2 (VR2) at the amino acid 
235.  
 
B.II.4 Expression and Purification of the constructs TPR-CS14-235 and TPR-
CS1-257 
  
The constructs TPR-CS14-235 and TPR-CS1-257 were expressed in the vector pGEX6-P1, 
possessing an N-terminal GST-tag. Best expression were observed for the fusion proteins 
GST-TPR-CST14-235 and GST-TPR-CSD1-257 in E. coli at 20°C for 18 h after induction in LB 
media. 
The proteins TPR-CST14-235 and TPR-CSD1-257 were purified without degradation products, 
as seen in SDS-PAGE electrophoresis of the fractions eluted from ion exchange 
chromatography (Figure B.10 a-d). ESI-MS confirmed the identity of the proteins by 
measuring a MW of 26238 kDa for the construct TPR-CS14-235 and 29126 Da for the 
construct TPR-CS1-257 .  
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Figure B.10) Ion exchange chromatography and SDS-PAGE analysis of the different constructs of SGT1. a) 
Profile of the cation-exchange chromatography of TPR-CS1-257 with a gradient of NaCl from 0 to 250 mM; b) 
refering SDS-PAGE analysis of the peak fractions as markerked in a); M= molecular weight marker c) 
Elution profile of cation-exchange chromatography of the TPR-CS14-235; d) refering SDS-PAGE analysis of 
the peak fractions, as marked in c). M= molecular weight marker. 
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B.II.5 Biophysical characterization 
B.II.5.a Size and oligomeric state 
The size exclusion chromatogram shows one symmetric peak, with minor shoulders, for 
each of the constructs TPR-CS14-235 and TPR-CS1-257. SDS-PAGE analysis revealed one clear 
band, indicating purity of the protein (Figure B.10).  
Static light scattering (SLS) confirmed a monomeric state for all of the constructs (Figures 
B.11 a-d). The obtained molecular weight was compared with the theoretical molecular 
weight calculated by the program protparam as enlisted in table 1. The full length protein 
SGT1 showed a molecular weight of 36.5 kDa +/- 1.5% which is in good agreement with 
the theoretical molecular weight of 38.6 kDa. The observed values for the molecular 
weight of the other constructs also agree with the predicted values (Table B.1).  
 
 
Figure B.11) SLS after SEC The UV280 signal (solid line) and the distribution of the molar mass (dotted line) 
vs. the elution volume are shown for a) the protein SGT1 and the constructs b) TPR-CSD1-257, c) TPR-CST14-235 
and d) SGS. The main peak of each chromatogram consists of a monomeric species of the respective protein. 
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Table B.1) Molecular weight of human SGT1 and the constructs TPR-CS1-257, TPR-CS14-235 and SGS. Shown 
are the molecular weights as determined by SLS after SEC. The theoretical molecular weight was calculated 
by the program protparam. 
 
 MW measured MW theoretical 
SGT1 36.5 kDa +/- 1.5 % 38.6 kDa 
TPR-CSD1-257 29.2 kDa +/-  0.9 % 29.1 kDa 
TPR-CST14-235 25.0 kDa +/- 1.4 % 25.3 kDa 
SGS 14.5 kDa +/- 3% 12.6 kDa 
 
B.II.5.b Fluorescence Spectroscopy 
Fluorescence spectra were recorded for the full length protein SGT1 and the isolated SGS 
domain in the presence and absence of the denaturating agent guanidinium-
hydrochloride (Figure B.12). Comparing the peak of SGT1 under non-denaturing 
condition to the peak of SGT1 in the denaturant, a shift of 12 nm is observed. This should 
confirm the folded state of SGT1, since this difference in the emission is typical for 
tryptophane residues which are in a hydrophobic environment in folded state and solvent 
exposed under denatured conditions.  
a)      b) 
 
Figure B.12) Fluorescence spectroscopy for a) the protein SGT1 and b) the SGS domain of SGT1. The images 
show the emission scans from 290 – 450 nm, after excitation by 280 nm. The measured intensity is given in 
counts per second. The spectra recorded in non denaturating buffer conditions is presented in blue, the 
spectra, recorded in denaturating buffer condition is presented in red. The wavelengths of the 
corresponding peaks are annotated in a box. 
 
The SGS domain on the other hand does not show such a shift. The emission maximum 
remains at 355 nm, which indicates that the tryptophane resdiues remain solvent exposed. 
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These results suggest that this domain does not have a well-defined fold in absence of a 
binding partner. 
 
B.II.5.c Secondary Structure determination 
A secondary structure analysis of the different constructs of SGT1 was performed by CD 
spectroscopy, measuring absorption of circular polarized light in the range of 240 - 200 
nm. The amount of the secondary structure was estimated using the three different 
programs K2D (Andrade, Chacon et al. 1993), K2D2 (Perez-Iratxeta and Andrade-Navarro 
2008) and SOM-CD (Unneberg, Merelo et al. 2001). 
 
 
 
Figure B.13 a-d) Circular Dichroism spectra of a) SGT1 b) TPR-CSD1-257 c) TPR-CST14-235 and d) SGS at 
RT. The absorbance from 200-240 nm is shown, the unit is mdeg. All spectra are measured in 20 mM 
Phosphate buffer, the reference buffer has already been subtracted. The spectra having minima at 207 nm 
and 222 nm resemble spectra of alpha-helical proteins.   
 
These three algorithms estimate totally different secondary structure (data not shown). 
Therefore the spectra were compared to the already published spectra of known 
secondary structure content. 
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The CD spectra of the constructs SGT1, TPR-CS1-257 and TPR-CS14-235 (Figures B.13 a-c) 
have local minima close to 208 nm and 222 nm, as it is observed for α-helical proteins, (ref 
4). These minima are caused by the TPR-domain, which is known to have high α-helical 
content and shows a comparable pattern (Nyarko, Mosbahi et al. 2007). The obtained 
spectra might be influence of the known β-sheet content of the CS-domain (Lee, Jacob et 
al. 2004) shifting the second minima to a lower wavelength (ref 5). 
 
In contrast, the profile of the SGS domain (Figure B.13d) resembles spectra of mainly 
unstructured proteins (ref 6) having low ellipticity above 210 nm and negative bands near 
195 nm (ref 6). This is in accordance with previous observations. Already Lee and 
coworkers assumed a low degree of folding of the SGS-domain. They compared the CD 
spectra for this domain to the spectra of the C-terminal domain of calcyclin-binding 
protein, known to have a limited degree of α-helical content. Since these spectra showed 
high similarity, therefore they assumed a limited degree of α-helical content for the SGS 
domain (Lee, Jacob et al. 2004). 
 
 
a)       b) 
.   
Figure B.14) NMR experiments of the SGS-domain of SGT at 295K a) 1H spectrum of SGS-domain    b) 
NOESY spectrum. 
 
To get an independent estimate for the folding of the SGS-domain, NMR spectroscopy in 
collaboration with Prof. O. Zerbe (Organic Institute) was performed. The [1H] spectrum of 
500 μM SGS shows only little signal dispersion above 8.5 ppm where signals of the 
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backbone amide protons of folded regions are expected to appear. The signals localized at 
10.1-10.2 ppm belong to the side chains of tryptophanes (Figure B.14a). Furthermore, a 
NOESY spectrum of the SGS domain, which is depicted in Figure B.14b does not show 
anycross peaks in the chemical shift range of 7.0 - 10.0 ppm. The absenceof these signals 
indicates the lack of secondary structure elements. Lee and co-workers (2004) concluded 
from their NMR experiments that this domain does not have a compact well folded 
globular structure.  
 
 
B.II.6 Optimization of buffer conditions for crystallization using the 
Thermofluor method 
 
The homogeneity of a protein sample, as well as its solubility and stability are important 
factors affecting the success of crystallization experiments.  
In order to enhance the possibility of crystallization of SGT1, the initial buffer 
formulation for the protein was investigated by the Thermofluor method (Ericsson, 
Hallberg et al. 2006). In this set-up, the protein was thermally denaturated under different 
buffer conditions. The hydrophobic dye SyproOrange was used to monitor the unfolding 
of the protein sample. The fluorescence of SyproOrange is quenched in aqueous solution, 
but the dye becomes fluorescent after binding to hydrophobic patches of proteins. Since 
protein denaturation makes these hydrophobic patches accessible to the dye, the increase 
of fluorescence monitors the unfolding of the protein. A shift towards higher melting 
temperatures (Tm) indicates that a certain buffer stabilizing the conformation of the 
protein. As seen in table 2 the protein SGT1 was most stable in sodium cacodylate with a 
Tm of 328 +/-0.2 K). Consequently, this buffer was used as a buffer for protein 
crystallization.  
 
 
 
 
 
 
 
Biophysical Characterization of SGT1  Results 
 
 70 
 
Table B.2) Thermal denaturation experiments of the protein SGT1 in different buffers covering the pH range 
from 4.5 - 8. All buffers have a concentration of 100 mM. The different thermal melting points (TM) and the 
errors are shown.  
 
Buffer (100 mM), pH Tm [K] error 
Imidazole, 8.0 312.2 0.1 
Sodium acetate, 4.5 316.5 0.5 
Hepes, 8.0 316.7 0.2 
Sodium Phosphate, 7.5 317.4 1.0 
Tris, 8.0 317.7 0.2 
Sodium citrate, 4.7 318.6 0.1 
Sodium acetate 5 319.9 0.0 
Tris, 7.5 320.5 0.2 
Potassium Phosphate, 5 321.8 0.1 
Mes, 5.8 321.9 0.1 
Bicine, 8 322.0 0.1 
Mes, 6.5 323.1 0.2 
Mes 6.2 323.9 0.1 
Ammonium acetate, 7.3 324.2 0.2 
Hepes, 7 325.2 0.2 
Potassium Phosphate, 6.0 325.2 0.1 
Sodium Phosphate, 5.5 325.7 0.1 
Sodium Phosphate, 6.5 325.8 0.1 
Sodium citrate, 5.5 327.8 0.2 
Potassium Phosphate, 7 327.8 1.1 
Sodium cacodylate, 6.5 328.0 0.2 
 
 
B.II.7 Crystallization experiments 
Up to now, a structure of the full length protein SGT1 is not available. Only the NMR 
structure of the CS domain of human SGT1 (Lee, Jacob et al. 2004) and the X-ray structure 
of a complex between the CS domain of SGT1 from A. thaliana and the N-terminal 
domain of HSP90 from barley has been determined (Zhang, Boter et al. 2008). Therefore, 
a structure of the full length protein would be of great interest. Crystallization 
experiments of the full length protein SGT1 as well as the constructs TPR-CS1-257 and TPR-
CS14-235  and SGS were performed. 
Preliminary ammonium sulphate precipitation screens revealed that SGT1 is most stable 
in pH conditions ranging from pH 7-8. This was also observed for the other constructs 
TPR-CS1-257, TPR-CS14-235 and SGS. 
Biophysical Characterization of SGT1  Results 
 
 71 
Crystallization was tried at varying protein concentration up to 30 mg/ml, which is the 
upper concentration limit of the full length protein. The initial buffer formulation was 20 
mM Tris, 10 mM NaCl, pH 7.5 or sodium cacodylate pH 6.5. Different crystallization 
screens, at 4°C and 20°C were exploited. Despite all these efforts, crystals were not 
obtained. 
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B.III Discussion 
 
The human protein SGT 1 was purified and characterized using different biophysical 
methods. Proteolysis resistant fragments, comprising the TPR and CS domain, were 
defined and corresponding constructs were cloned, purified and characterized. 
 
The full length human protein SGT1 is monomeric and has a certain degree of α-helical 
content as determined by static light scattering and circular dichroism analysis. This 
degree could not be determined precisely, neither by our work, nor by previous studies 
(Lee, Jacob et al. 2004). Interestingly, the oligomerization state depends on the origin of 
the protein. SGT1 of yeast, barley and Arabidopsis are dimers. Dimer formation is 
mediated by the TPR domain (Nyarko, Mosbahi et al. 2007).  
 
Since full length SGT1 is highly sensitive to proteolysis, two proteolysis resistant 
fragments were found by limited proteolysis experiments. These fragments comprised the 
TPR and the CS domains. They were purified as folded, monodisperse proteins without 
degradation products and showed defined secondary structure in CD spectroscopy. The 
CD spectra resemble the recorded spectra for the TPR-domain of barley that is well-
known of its high α-helical content (Figure 12)  (Nyarko, Mosbahi et al. 2007). The CS 
domain is mainly composed of β-sheets, which has been determined by NMR (Lee, Jacob 
et al. 2004) and X-ray crystallography (Zhang, Boter et al. 2008). 
Even though we could successfully precipitate transiently expressed NLRP3 by 
immunoassays (G. Hausammann), using the recombinant SGT1, which requires a 
functional CS domain, as well as the SGS domain (Mayor, Martinon et al. 2007), our 
experimental findings confirmed, that the SGS domain without interaction partner is 
mainly disordered. The CD spectrum of this domain (Figure 12d) resembles the spectrum 
of a mainly unstructured protein (Greenfield 2006). Lee and (2004) already assumed a 
limited degree of α-helical content for the SGS domain, by comparing the spectrum with 
the CD spectrum of the C-terminal domain of calcyclin-binding protein (Nowotny, 
Spiechowicz et al. 2003). Also, of the NMR spectrum of the SGS domain described here 
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does not show any noteworthy secondary structure, as it was already indicated by earlier 
NMR experiments (Lee, Jacob et al. 2004). An induced folding in the presence of a binding 
partner can be suggested. 
Previous analytical ultracentrifugation studies conducted in our lab, showed an unusual 
elevated frictional ratio (Hausammann 2007). This result and the known proteolysis 
sensitivity of this protein go along with the lack of secondary structure in the last domain.  
 
It is known that the SGS-domain of yeast SGT1 binds S100A6 (calcyclin) and other 
members of the S100 protein family (Nowotny, Spiechowicz et al. 2003). In order to 
investigate the binding characteristics and the possibility of induced folding of the SGS 
domain, further studies in presence of these interaction partners, are of high interest. 
 
Crystallization experiments were performed with the full length protein and the stable 
constructs comprising the first two domains, however no crystals could be obtained.  
It is known that flexible parts in a protein can impede crystal formation (Wernimont and 
Edwards 2009).  Even though the unstructured domain is excluded in the new constructs, 
the first two domains are connected by a presumed flexible linker (Lee, Jacob et al. 2004). 
Co-crystallization of the first two domains with an interaction partner such as DARPins 
and scFabs holding the domains in a stable conformation would be a promising approach 
to determine the structure of the first two domains of SGT1 together. 
 
The protein and its constructs serve as valuable tools for further immuno-precipitation 
studies such as the determination and qualitative characterization of components of the 
inflammasome and other interaction partners found in the plant pathogen response and in 
the cell cycle regulation. This has already been realized by immunoprecipitating NLP3 
from transiently infected HEK293T cells (Hausammann 2007) and inflammasome 
components (Mayor, Martinon et al. 2007). 
 
Biophysical Characterization of SGT1  Material and Methods 
 74 
B.IV Material and Methods 
 
B.IV.1 Constructs of human SGT1b 
The gene of human SGT1b (NM_006704) and its SGS domain were encoded on the 
plasmids pGEX6P-1-SGT1b and pGEX6P-1-SGS as a fusion protein to glutathione-S-
transferase of E. coli. These vectors were a kind gift of J. Tschopp, University of Lausanne. 
 
For the constructs TPR-CSD1-257 and TPR-CST14-235, originating from limited proteolysis 
experiments, PCR was done on the vector pGEX-6-P1-SGT1p with the synthetic oligos 
(Microsynth, Balgach) Fw & Rev (see table B.3). PCR fragments were subcloned in the 
vector pGEX-6-P1 (Amersham) using the restriction sites EcoRI/XhoI sites. Sequences 
were verified by sequencing at Synergene (Schlieren). 
. 
 
Table B.3) Primers for cloning the constructs of SGT1.  
Construct primer Sequence Tm 
TPR-CSD1-
257  
Fw TATAGAATTCATGGCGGCGGCTGC 
 
64.6 
 
 rev 
 
GAATCTCGAGCTAATAAGGAGATGATGATGGATATAG 
 
63.3 
 
TPR-CST14-
235 
Fw ATTGAATTCTTTTTCCAGAGCTTCTCGGATGC 66.5 
 Rev CATCTCGAGCTATTGTTTTGGCGTAGGCAC 
 
66.7 
 
 
B.IV.2 Overexpression of human SGT1 and the constructs 
The proteins were over-expressed in E.coli BL21(DE3) cells in 500 ml LB medium 
supplemented with ampicillin (0.1g/l). Protein production was induced by addition of 0.1 
mM isopropyl-β-D-thiogalactopyranoside (IPTG) at an OD600 of 0.6. The constructs GST-
SGT1, GST-TPR-CSD1-257 and GST-TPR-CST14-235 were over-expressed at 20°C for 16 h, the 
construct GST-SGS was over-expressed at 37°C for 4 h. Cells were harvested by 
centrifugation and stored by -20°C.   
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B.IV.3 Purification of the proteins 
The cell pellets of 4 l bacterial culture were resuspended and lysed in 100 ml Lysis Buffer 
(10 mM Tris pH 8, 150 mM NaCl, 1 mM DTT, Complete Protease Inhibitor (Roche), 
2.5mg/ml DNase, 2mg/ml lysozyme) using the Emulsiflex (Avestin). After the removal of 
the residual cell debris by centrifugation and filtration with a 0.2 μm filter (Filtropur, 
Sarstedt) the protein was purified over a GSTrap colum (GE healthcare), washed with 
Wash Buffer (TBS pH 8, 1 mM DTT) and eluted with Elution Buffer (50 mM Tris, 150 mM 
NaCl, pH8, 10 mM glutathione, 1 mM DTT). The proteins were dialysed in cleavage 
buffer (50 mM Tris pH 7, 150 mM NaCl, 1 mM EDTA, 1 mM DTT) and incubated with 
PreScission protease overnight at 4°C (8 μl stock solution/mg of GST-SGT1). The 
PreScission-protease, GST-tag and endogenous GST were removed by a second passage 
over the GSTrap column. After dialysis (membrane Spectra/Por, spectrumlabs, MWCO 
12000-14000 Da) into ion-exchange buffer A, ion exchange chromatography was 
performed. Protein was eluted by a gradient of 50 X column volumes to 50% of buffer B. 
For the proteins SGT1, TPR-CSD1-257 and TPR-CST14-235 cation exchange chromatography 
was performed with the means of a 1 ml ResS column (GE healthcare). For SGS anion 
exchange chromatography was performed with the means of a 1 ml ResQ column (GE 
healthcare). The Anion exchange Buffers were A: 20 mM HEPES pH 7.5, TCEP; B: 20 mM 
HEPES pH 7.5, TCEP, 250 mM NaCl. Cation exchange buffers were A: 20 mM NaAc pH 
5.5, TCEP; B: 20 mM NaAc pH 5.5, TCEP, 250 mM NaCl. Elution was at 6.4 mS/cm for 
SGT1, 6.31 mS/cm for SGS, 8.3 mS/cm for TPR-CSD1-257 and 4.5 mS/cm for TPR-CST14-235. 
The peak fractions were pooled and concentrated using Amicon Ultra-4 (Millipore) 
concentrators with a molecular weight cut off (MWCO) of 10 kDa. 
 
B.IV.4 Determination of proteolysis resistant fragments by limited 
proteolysis 
Purified protein SGT1b was kept for 10 days at RT. Aliquots were taken after 0, 4 and 10 
days and denaturated in SDS-PAGE buffer. The samples were loaded on a 12 % SDS-
PAGE for further analysis or given directly for mass spectrometry analysis.  
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Purified protein SGT1 was incubated with trypsin in a molar ratio of 1/1000. 5 reactions 
were started. The reactions were stopped by denaturating in SDS-PAGE loading buffer 
after 0, 20, 40 and 90 min. The samples were loaded on a 12% SDS-PAGE, before Western 
Blotting. Bands were cut out for N-terminal sequencing. 
Mass spectrometry requires protein samples free of loading buffer. For this purpose the 
reaction was stopped by TCA precipitation. 
One volume of 100% TCA stock was added to 4 volumes of protein sample and incubated 
at 4°C for 10 min. Then the sample was centrifuged for 5 min at 16 000 g. After removal of 
the supernatant, the pellet was washed two times with 200 μl of ice-cold acetone. The 
pellet was finally centrifuged down and dried at 95°C. Mass spectrometry was done at the 
Protein Analysis Unit of the Functional Genomics Centre Zurich. The sample for TPR-
CST14-235 was analyzed by MALDI-MS and Edman-sequencing; whereas the sample for 
TPR-CSD1-257 was analyzed by ESI-MS. Corresponding fragments were determined with 
the software GPMAW (Peri, Steen et al. 2001). 
B.IV.5 Size and oligomeric state determination 
Multi angle light scattering was performed after size exclusion chromatography in TBS 
with the help of a S200 column (GE Healthcare). The Tri-Angle Light Scattering Detector 
miniDAWN (Wyatt) measured the intensity of the scattered light at the angles 45°, 90° 
and 135° and the OPTILAB REX rEX was used as a concentration detector, which 
measured the optical phase difference at the fixed wavelength of 690 nm. An internal 
calibration run with 100 μl of 2.5mg/ml of BSA was used to detect the correct setting of 
the dead volume and the delay of the system. The runs with the proteins were done with 
100-200 μl of protein at a concentration of 2.0 mg/ml. Curves were evaluated using the 
ASTRA software. 
 
B.IV.6 Fluorescence Spectroscopy 
Fluorescence spectra of 20mg/ml protein sample were recorded in 20 mM phosphate 
buffer pH 7 in presence and absence of 4 M guanidinium hydrochloride. The sample was 
excitated using light at 280 nm; the emission spectrum was recorded in the range of 290 - 
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450 nm in order to detect tryptophane fluorescence with the Fluoromax-4 (HoribaJobin 
Yvon). Reference spectra without protein were subtracted from the measured spectra. 
 
B.IV.7 Circular Dichroism 
Circular Dichroism spectra measurements were performed with a Jasco J-715 instrument 
(Jasco, Japan) at 4 °C. CD spectra were recorded in the wavelength range of 190-245 nm. 
The cuvette had a pathway length of 0.1 cm and held a volume of 200 μl. The protein was 
dialyzed overnight in 20 mM phosphate buffer purged under bubbling nitrogen. 
Measurements were performed at protein concentrations of 20 μM. The reference spectra 
were carried out with the buffer alone. The sensitivity was 100 mdeg and the spectra were 
recorded at a speed of 20 nm/min. Three accumulations were acquired for one spectrum. 
 
B.IV.8 NMR 
NMR measurements were done by Oliver Zerbe at the Institute of Organic Chemistry of 
the University of Zurich. The protein sample was measured in 20 mM phosphate, 50 mM 
NaCl buffer. The protein concentration was 500 μM. 1H spectrum and NOESY spectra 
were recorded at 295 K. 
 
B.IV.9 Thermal shift assays 
7.5 μl of Sypro Orange (300x), 10 μl of SGT1 (60 μM) in 20 mM Tris, 20 mM NaCl and 7.5 
μl of testing buffer (Table B.4) were added to the wells of a 96 well PCR plate (BioRAD). 
The plates were sealed with Optical-Quality Sealing Tape (BioRAD) and heated in an 
iCycleriQ Real Time PCR Detection System (BioRAD) from 20 to 70 °C in increments of 
0.5 °C. The samples were excitated at 490 nm, the fluorescence changes in the wells of the 
plate were monitored at 575 nm. 
The Boltzmann model with the formula (1) was used in order to fit the fluorescence 
curves obtained with the software Origin (OriginLab). Data points after the fluorescence 
intensity maximum were excluded from fitting. 
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(1)  I=[A+(B-A)/(1+e(Tm-T)/C] 
I= fluorescence intensity  
T= temperature 
A & B = fluorescence intensities before and after the transition, respectively 
C= slope factor 
 
 
Table B.4) Testing buffers were used at a concentration of 100mM: 
Buffer, pH pH 
Na acetate 4.5 
Na citrate 4.7 
Na acetate 5.0 
K Pi 5.0 
Na Pi 5.5 
Na citrate 5.5 
Mes 5.8 
K Pi 6.0 
Mes 6.2 
Na Pi 6.5 
Na cacodylate 6.5 
Buffer, pH pH 
Mes 6.5 
K Pi 7.0 
Hepes 7.0 
NH4 acetate 7.3 
Na Pi 7.5 
Tris 7.5 
Imidazole 8.0 
Hepes 8.0 
Tris 8.0 
Bicine 8 
 
B.IV.10 Crystallization experiments 
Crystallization screens for all of the four constructs were set up at a multitude of 
conditions, with varying protein concentrations up to the solubility limit, which is around 
30 mg/ml in 20mM Tris pH 7.5, 20 mM NaCl. The screening was carried out at the NCCR 
crystallization facility in small scale in drop sizes of 100-200 nl in 96-well crystallization 
plates (greiner, crystal quick). All screens were done by vapour-diffusion in sitting drops 
against different reservoir buffer conditions. The ratio protein/buffer was used at 2:1, 1:1 
and 1:2 at incubation temperatures at 4°C and at 20°C..  The screens used were the Clear 
Strategy (Molecular Dimensions) screen with the buffer range of pH 5.5 to pH 8.5, Sigma-
Fluka Factorial Screen, PEG4000/8000, PEG4000/6000, JCSG+ Suite (Nextal), Pact Suite 
Biophysical Characterization of SGT1  Material and Methods 
 79 
Crystal (Nextal), Structure Screen I&II (Molecular Dimensions) and the Sigma-Fluka 
screens #73513 #86684 and #75403. 
Pictures of the crystallization trials were taken by the crystal farm immediately after setup 
and after 1, 4, 7, 10, 13, 28, 58 and 88 days. 
Biophysical characterization of SGT1  Literature 
 
 
 80 
B.IV Literature: 
 
 
Aganna, E., F. Martinon, et al. (2002). "Association of mutations in the 
NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold 
sensitivity, sensorineural deafness, and AA amyloidosis." Arthritis Rheum 46(9): 
2445-52. 
Agostini, L., F. Martinon, et al. (2004). "NALP3 forms an IL-1beta-processing 
inflammasome with increased activity in Muckle-Wells autoinflammatory disorder." 
Immunity 20(3): 319-25. 
Alheim, K. and T. Bartfai (1998). "The interleukin-1 system: receptors, ligands, and ICE in 
the brain and their involvement in the fever response." Ann N Y Acad Sci 840: 51-8. 
Ali, M. M., S. M. Roe, et al. (2006). "Crystal structure of an Hsp90-nucleotide-p23/Sba1 
closed chaperone complex." Nature 440(7087): 1013-7. 
Andrade, M. A., P. Chacon, et al. (1993). "Evaluation of secondary structure of proteins from 
UV circular dichroism spectra using an unsupervised learning neural network." 
Protein Eng 6(4): 383-90. 
Azevedo, C., S. Betsuyaku, et al. (2006). "Role of SGT1 in resistance protein accumulation 
in plant immunity." Embo J 25(9): 2007-16. 
Azevedo, C., A. Sadanandom, et al. (2002). "The RAR1 interactor SGT1, an essential 
component of R gene-triggered disease resistance." Science 295(5562): 2073-6. 
Azpiroz, M. F., E. Rodriguez, et al. (2001). "The structure, function, and origin of the 
microcin H47 ATP-binding cassette exporter indicate its relatedness to that of colicin 
V." Antimicrob Agents Chemother 45(3): 969-72. 
Bieri, S., S. Mauch, et al. (2004). "RAR1 positively controls steady state levels of barley 
MLA resistance proteins and enables sufficient MLA6 accumulation for effective 
resistance." Plant Cell 16(12): 3480-95. 
Boter, M., B. Amigues, et al. (2007). "Structural and functional analysis of SGT1 reveals that 
its interaction with HSP90 is required for the accumulation of Rx, an R protein 
involved in plant immunity." Plant Cell 19(11): 3791-804. 
Biophysical characterization of SGT1  Literature 
 
 
 81 
Breeden, L. and K. Nasmyth (1987). "Similarity between cell-cycle genes of budding yeast 
and fission yeast and the Notch gene of Drosophila." Nature 329(6140): 651-4. 
Catlett, M. G. and K. B. Kaplan (2006). "Sgt1p is a unique co-chaperone that acts as a client 
adaptor to link Hsp90 to Skp1p." J Biol Chem 281(44): 33739-48. 
da Silva Correia, J., Y. Miranda, et al. (2007). "SGT1 is essential for Nod1 activation." Proc 
Natl Acad Sci U S A 104(16): 6764-9. 
Dode, C., N. Le Du, et al. (2002). "New mutations of CIAS1 that are responsible for Muckle-
Wells syndrome and familial cold urticaria: a novel mutation underlies both 
syndromes." Am J Hum Genet 70(6): 1498-506. 
Dubacq, C., R. Guerois, et al. (2002). "Sgt1p contributes to cyclic AMP pathway activity and 
physically interacts with the adenylyl cyclase Cyr1p/Cdc35p in budding yeast." 
Eukaryot Cell 1(4): 568-82. 
Ericsson, U. B., B. M. Hallberg, et al. (2006). "Thermofluor-based high-throughput stability 
optimization of proteins for structural studies." Anal Biochem 357(2): 289-98. 
Fritz, J. H., R. L. Ferrero, et al. (2006). "Nod-like proteins in immunity, inflammation and 
disease." Nat Immunol 7(12): 1250-7. 
Greenfield, N. J. (2006). "Using circular dichroism spectra to estimate protein secondary 
structure." Nat Protoc 1(6): 2876-90. 
Hausammann, G. (2007). Expression and Structural Analysis of the Human SGT1. Insitute of 
Biochemistry. Zurich, University of Zurich. Master: 47. 
Jones, J. D. and J. L. Dangl (2006). "The plant immune system." Nature 444(7117): 323-9. 
Kadota, Y., B. Amigues, et al. (2008). "Structural and functional analysis of SGT1-HSP90 
core complex required for innate immunity in plants." EMBO Rep 9(12): 1209-15. 
Kitagawa, K., D. Skowyra, et al. (1999). "SGT1 encodes an essential component of the yeast 
kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase 
complex." Mol Cell 4(1): 21-33. 
Koonin, E. V. and L. Aravind (2000). "The NACHT family - a new group of predicted 
NTPases implicated in apoptosis and MHC transcription activation." Trends Biochem 
Sci 25(5): 223-4. 
Biophysical characterization of SGT1  Literature 
 
 
 82 
Krippner-Heidenreich, A., R. V. Talanian, et al. (2001). "Targeting of the transcription factor 
Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual 
glutamic acid residue in position P1." Biochem J 358(Pt 3): 705-15. 
Lee, Y. T., J. Jacob, et al. (2004). "Human Sgt1 binds HSP90 through the CHORD-Sgt1 
domain and not the tetratricopeptide repeat domain." J Biol Chem 279(16): 16511-7. 
Martinon, F., L. Agostini, et al. (2004). "Identification of bacterial muramyl dipeptide as 
activator of the NALP3/cryopyrin inflammasome." Curr Biol 14(21): 1929-34. 
Martinon, F., K. Burns, et al. (2002). "The inflammasome: a molecular platform triggering 
activation of inflammatory caspases and processing of proIL-beta." Mol Cell 10(2): 
417-26. 
Martinon, F., O. Gaide, et al. (2007). "NALP inflammasomes: a central role in innate 
immunity." Semin Immunopathol 29(3): 213-29. 
Martinon, F., V. Petrilli, et al. (2006). "Gout-associated uric acid crystals activate the NALP3 
inflammasome." Nature 440(7081): 237-41. 
Martinon, F. and J. Tschopp (2004). "Inflammatory caspases: linking an intracellular innate 
immune system to autoinflammatory diseases." Cell 117(5): 561-74. 
Martinon, F. and J. Tschopp (2005). "NLRs join TLRs as innate sensors of pathogens." 
Trends Immunol 26(8): 447-54. 
Martinon, F. and J. Tschopp (2007). "Inflammatory caspases and inflammasomes: master 
switches of inflammation." Cell Death Differ 14(1): 10-22. 
Mayor, A., F. Martinon, et al. (2007). "A crucial function of SGT1 and HSP90 in 
inflammasome activity links mammalian and plant innate immune responses." Nat 
Immunol 8(5): 497-503. 
Meylan, E. and J. Tschopp (2005). "The RIP kinases: crucial integrators of cellular stress." 
Trends Biochem Sci 30(3): 151-9. 
Nadiri, A., M. K. Wolinski, et al. (2006). "The inflammatory caspases: key players in the 
host response to pathogenic invasion and sepsis." J Immunol 177(7): 4239-45. 
Nowotny, M., M. Spiechowicz, et al. (2003). "Calcium-regulated interaction of Sgt1 with 
S100A6 (calcyclin) and other S100 proteins." J Biol Chem 278(29): 26923-8. 
Nyarko, A., K. Mosbahi, et al. (2007). "TPR-Mediated self-association of plant SGT1." 
Biochemistry 46(40): 11331-41. 
Biophysical characterization of SGT1  Literature 
 
 
 83 
Poyet, J. L., S. M. Srinivasula, et al. (2001). "Identification of Ipaf, a human caspase-1-
activating protein related to Apaf-1." J Biol Chem 276(30): 28309-13. 
Schwartz, S., Jr., H. Yamamoto, et al. (1999). "Frameshift mutations at mononucleotide 
repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer 
of the microsatellite mutator phenotype." Cancer Res 59(12): 2995-3002. 
Shirasu, K. (2008). "The HSP90-SGT1 Chaperone Complex for NLR Immune Sensors." 
Annu Rev Plant Biol. 
Shirasu, K., T. Lahaye, et al. (1999). "A novel class of eukaryotic zinc-binding proteins is 
required for disease resistance signaling in barley and development in C. elegans." 
Cell 99(4): 355-66. 
Shirasu, K. and P. Schulze-Lefert (2003). "Complex formation, promiscuity and multi-
functionality: protein interactions in disease-resistance pathways." Trends Plant Sci 
8(6): 252-8. 
Unneberg, P., J. J. Merelo, et al. (2001). "SOMCD: method for evaluating protein secondary 
structure from UV circular dichroism spectra." Proteins 42(4): 460-70. 
Wernimont, A. and A. Edwards (2009). "In situ proteolysis to generate crystals for structure 
determination: an update." PLoS One 4(4): e5094. 
Ye, Z. and J. P. Ting (2008). "NLR, the nucleotide-binding domain leucine-rich repeat 
containing gene family." Curr Opin Immunol 20(1): 3-9. 
Zhang, M., M. Boter, et al. (2008). "Structural and functional coupling of Hsp90- and Sgt1-
centred multi-protein complexes." Embo J 27(20): 2789-98. 
 
Structural Determinants improving the thermal stability of DARPins  Introduction 
 84 
Chapter - C. Structural Determinants for improved thermal 
stability of Designed Ankyrin Repeat molecules 
 
C.I) Introduction 
Ankyrin repeat motifs can be exploited as stable binding partners for proteins for a wide 
variety of purposes, such as medical applications, biochemical methods and as partners for 
co-crystallization for X-ray structure determination. In order to obtain high quality 
binding partners for proteins of interest Binz and co-workers created Designed Ankyrin 
Repeat Proteins (DARPins). These proteins are based on a consensus design, and are 
characterized to be extremely stable (Binz, Stumpp et al. 2003).  
 Experimental studies and Molecular Dynamics simulation have demonstrated that 
the carboxy-terminal capping repeat (C-cap) of these DARPins is denaturing first, 
followed by the ankyrin body (Yu, Kohl et al. 2006; Interlandi, Wetzel et al. 2008). 
Several mutations have been proposed by molecular dynamics (MD) simulations in order 
to fortify this C-cap, thereby increasing the overall stability of the protein. The stability of 
the mutants carrying the proposed mutations were determined by thermal and chemical 
unfolding kinetics of the NI1C, a designed full consensus ankyrin repeat protein, 
possessing only one internal repeat (Interlandi, Wetzel et al. 2008). 
 
Also for the use of these binding proteins as a crystallographical tool, it is of outstanding 
interest to fortify the C-cap. It has been observed, that the electron density of the C-cap is 
poorly defined in most of the known DARPin structures. For the ankyrin F8, a selected 
DARPin inhibitor of caspase 2, no electron density has been found for residues 154 to 166, 
neither in the complex with caspase-2 nor crystallized without a binding partner 
(Schweizer, Roschitzki-Voser et al. 2007). Better crystallographic results were achieved by 
using a DARPin with a deleted C-cap for crystallizing the kinase domaine of the Polo-like 
kinase1 (Plk1). Here the absence of the C-cap enhanced the binding of the DARPin to the 
Plk1 by the formation of a closed tail to tail contact between the two DARPins bound to 
the protein. (Bandeiras, Hillig et al. 2008).  
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The focus of this project in my PhD thesis was on the following questions: What 
are the structural determinants for the improved stabilities of the C-cap mutants. The 
crystal structures of the DARPin C-cap mutants NI1C mutant 4, NI3C mutant 5, and NI3C 
mutant 6 were solved by X-ray crystallography.  
The crystal structures were the basis for a detailed analysis of structural factors 
contributing to the higher stability. The important characteristics of the interfaces of the 
ankyrin body to the C-cap, such as surface area, shape complementarity, hydrogen-
bonding network and salt bridges were investigated in detail. 
 
The mutants 5 and 6 possess the highest number of point mutations and reveal 
conformational changes in the positioning of the C-cap, which are described as a rigid 
body movement of the C-cap towards the body of the ankyrin structure. Consequently the 
number of hydrophobic contacts and H-bonds are increased and fortify the interactions in 
the interface between the ankyrin body and the C-cap (NIII-C). The geometrical shape 
and the buried surface area of the interrepeat interfaces is altered, a better stacking of the 
C-cap to the last internal repeat is enhanced.  
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Abstract 
Designed ankyrin-repeat proteins (DARPins) serve as very versatile protein recognition 
modules, because DARPins against almost any target molecule can be obtained by using 
library based combinatorial techniques. Although DARPins are already extremely stable 
molecules, heat denaturation experiments, structural studies and molecular dynamics 
simulations suggested that the unfolding of the C-terminal capping repeat limits the 
stability of the initial DARPin design. Using the consensus sequence of the internal 
repeats as a guide, several point mutations were suggested to optimize the design of the 
C-terminal capping repeat. These mutations were introduced and the crystal structures of 
the more stable DARPins NI1C mutant 4, NI3C mutant 5 and NI3C mutant 6 were refined 
at 2.2 Å, 2.1 Å and 1.8 Å resolution, respectively. In the optimized design the C-terminal 
capping repeat has moved as a rigid body towards the preceding internal repeat. This 
movement generates an increased buried surface area and superior surface 
complementarities, which explains the improved thermal stability compared to the initial 
scaffold design.  
Introduction 
Repeat proteins are the most abundant class of naturally occurring protein-protein 
interaction modules. They are found in all kingdoms of life and constitute rather simple 
architectures, consisting of structurally identical repeats that are stacked together to form 
an elongated none-globular protein domain. Multi-repeat proteins serve as unique 
templates for protein engineering experiments, because their stabilities are dominated by 
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intra-repeat interactions and interactions between neighbouring repeats. (Bork 1993; 
Andrade, Perez-Iratxeta et al. 2001)  
Several classes of multi repeat proteins exist. Besides armadillo-, tetratricopeptide- and 
leucine-rich repeat proteins (Main, Xiong et al. 2003; Stumpp, Forrer et al. 2003; 
Parmeggiani, Pellarin et al. 2008) members from the family of ankyrin repeats (AR) have 
probably been most often used as protein engineering templates. The AR consists of two 
anti-parallel α-helices and a short β-turn. Two different approaches have been applied to 
design AR proteins by protein engineering. (Mosavi, Minor et al. 2002; Binz, Stumpp et 
al. 2003) Both approaches relied on the design of consensus sequences that were 
assembled based on large collections of naturally occurring AR sequences. Although both 
approaches resulted in stable AR proteins with different numbers of repeats, the design of 
Mosavi et al. (2002) yielded proteins that were only soluble at the acidic pH range, 
whereas the approach of Binz et al. (2003) yielded proteins that were soluble over a 
larger pH range. The incorporation of N- and C-terminal capping repeats greatly 
improved the solubility of these DARPins and they were subsequently used as very 
versatile and selective protein-protein interaction modules for biochemical and 
biophysical studies. Crystal structures of isolated DARPins and DARPins in complex 
with various target proteins have been determined. (Kohl, Binz et al. 2003; Amstutz, Binz 
et al. 2005; Kohl, Amstutz et al. 2005) 
DARPins that were generated following the design of Binz et al. (2003) are described as 
NIxC molecules, where N, I, and C represent the N-terminal, internal and C-terminal 
repeats and x indicates the number of internal repeats. Internal repeats consist of 33 
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residues each; 27 of them serve as framework residues, which are conserved in all 
internal repeats, and 6 residues are selected by combinatorial techniques, such as 
ribosome display, to recognize the target molecule. In full-consensus DARPins the amino 
acid sequences of all internal repeats are exactly identical.  
DARPins are extremely stable molecules. Generally the stabilities of full-consensus 
DARPins increase with the number of internal repeats and DARPins with more than two 
internal repeats can not be denatured by heat treatment alone. (Interlandi, Wetzel et al. 
2008; Wetzel, Settanni et al. 2008) Depending on the ionic strength the full-consensus 
NI3C possesses melting temperatures between 74 °C and 80 °C even in the presence of 4 
M GdnHCl. (Merz, Wetzel et al. 2008; Wetzel, Settanni et al. 2008) Comparison of 
several DARPin crystal structures revealed that the C-terminal capping repeats possess 
the largest structural flexibilities. (Kohl, Binz et al. 2003; Binz, Kohl et al. 2006; Merz, 
Wetzel et al. 2008) Molecular dynamics calculations of the none full-consensus E3_5 and 
E3_19 (Yu, Kohl et al. 2006) and several full-consensus NI1C and NI3C DARPin 
structures (Interlandi, Wetzel et al. 2008) showed, that the C-terminal capping repeat 
possesses the lowest structural stability. Indeed, NI3C showed a bi-phasic behaviour in 
GdnHCl induced unfolding experiments, whereas NI3 showed a clear mono-phasic 
behaviour. Since NI3 lacks the C-terminal capping repeat, the pre-transition in NI3C 
unfolding experiments was interpreted as the premature unfolding of the C-terminal 
capping repeat. (Interlandi, Wetzel et al. 2008)  
Since the C-terminal capping repeats prevent the formation of insoluble aggregates and in 
order to improve the temperature stabilities of DARPin molecules even further, Interlandi 
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et al. (2008) suggested six mutations to improve the packing between the C-terminal 
capping repeat and the preceding internal repeat (Table 1). In contrast to the design of 
Binz et al. (2003), where the C-terminal capping repeat was taken from the guanine-
adenine binding protein β1, the new design was inspired by the consensus sequence of 
the internal repeats. To investigate the structural consequences of those mutations we 
determined the crystal structures of NI3C mutants 5 and 6 as well as NI1C mutant 4 and 
compared them to the crystal structure of the ancestor molecule NI3C. (Merz, Wetzel et 
al. 2008) Interestingly many full-consensus DARPins are prone to form twinned crystals, 
which was overcome by using ammonium sulphate as the crystallization agent.  
Results 
Structure of NI1C mutant 4 
The crystal structure of NI1C was determined at 2.2 Å resolution and folds into a compact 
globular molecule with overall dimensions of 17 · 24 · 25 Å (Fig. 1a). The structure 
reveals clear electron density for amino acids 13 to 103, which are sub-divided into the 
N-terminal capping repeat (residues 13-43), the internal repeat (residues 44-76) and C-
terminal capping repeat (residues 77-103). Although several crystal structures of 
DARPins with three internal repeats have been determined, the present structure of NI1C 
mutant 4 serves as the prototype structure for a DARPin with just one internal repeat. The 
NI1- (residues 13 to 76) and I1C repeat pairs (residues 43 to 100) of NI1C mutant 4 
superimpose perfectly onto the corresponding N- and C-terminal pairs of NI3C wild type 
with rmsds of 0.47 Å (66 Cα-atoms) and 0.46 Å (54 Cα-atoms), respectively. The N-, I- 
and C-terminal repeats of  NI1C reveal average B-factors of 19.1 Å2, 24.7 Å2 and 22.6 Å2, 
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respectively. Thus, in contrast to previously determined structures of DARPins with three 
internal repeats, there is just a very moderate B-factor gradient present in NI1C mutant 4, 
suggesting that the mutations effected the flexibility of the C-terminal capping repeat. 
The C-terminal capping repeat of NI1C mutant 4 deviates from the capping repeat of 
NI3C wild type by a three amino acid extension of the second C-terminal capping repeat 
helix (helix B). As it has been anticipated during the design process, residues Lys101-Ala-
Ala103 adopt an α-helical conformation and participate in the hydrogen bonding network 
of helix B. The side chain of Lys101 serves as a C-terminal helix-cap, but forms no direct 
hydrogen bonds with the C-terminus of helix B. Instead Lys101 forms a surface exposed 
salt bridge with the side chain of Glu97. Furthermore, the Cα-atom of Ala103 is located 
at VdW distance to the side chain of Val73 from the preceding internal repeat.  
NI1C mutant 4 shows a markedly different side chain packing at the interface between 
internal- and C-terminal repeats (Fig. 1b). In NI1C mutant 4 the side chain of His52 forms 
a salt bridge with the side chain of Asp77, whereas in NI3C the equivalent His118 
interacts with Thr115. The movement of His52 causes the rotation of the side chains of 
Ile86, Ser87 and Leu95, since they are all at VdW distance to one another. In NI1C 
mutant 4 Ser87-OG forms a hydrogen bond with Ala83-O (3.05 Å). Since none of the 
rotated side chains are in direct contact with the Lys101-Ala-Ala103 extension of helix B, 
the observed movements could be the consequence of different crystallization conditions. 
NI1C mutant 4 was crystallized at pH 5.0 and in the presence of 30 % methanol, whereas 
NI3C wild type was crystallized at pH 8.5 and in the absence of methanol. Neither the 
extension of helix B nor the different side chain conformations of His52, Ile86, Ser87 and 
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Leu95 have a significant effect on the conformation of the capping repeat main chain. 
Thus, the spatial orientations of the C-terminal capping repeats relative to the last internal 
repeats are almost identical in the structures of NI3C wild type and NI1C mutant 4.   
Structures of NI3C mutants 5 and -6 
NI3C mutants 5 and -6 crystallized with 4 and 3 molecules in the asymmetric units and 
were refined at 2.1 Å and 1.8 Å resolution, respectively. The structures of the N-terminal 
capping repeats and the internal repeats of both mutants were almost identical to the 
corresponding repeats of the NI3C wild type (Fig. 2a). Superposition of Cα atoms of 
residues 13 to 76 from 2QYI (Merz, Wetzel et al. 2008) onto mutants 5 and -6 revealed 
rmsds of 0.31±0.01 Å and 0.24±0.04 Å, respectively. Larger structural changes are seen 
at the interfaces between the last internal repeats and the C-terminal capping repeats. 
Superposition of residues 110 to 166 (corresponding to the last internal repeat and the C-
terminal capping repeat) revealed rmsds of 0.78±0.01 Å and 0.68±0.07 Å for mutants 5 
and -6, respectively. In mutants 5 and -6 the C-terminal capping repeats have moved as 
rigid bodies towards the last internal repeats (Fig. 2b). The largest movements are seen 
for residues 154 to 160, which form the loop between helices A and -B of the C-terminal 
capping repeat. These residues have moved approximately 2 to 3 Å towards the last 
internal repeat (Fig. 2b). The redesign also increased the buried surface area of the 
interface between the last internal repeat and the capping repeat from 625 Å2 in NI3C 
wild type to 720±6 Å2 and 723±6 Å2 in mutants 5 and -6, respectively. Simultaneously 
mutants 5 and -6 show improved surface complementarities compared to the wild type 
interface (Table 1). 
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The rigid body movement of the capping repeat is a consequence of the new interface 
design. Mutant 5 deviates from the NI3C wild type (Table 1) by a 3 amino acid extension 
of helix B (similar to NI1C mutant 4) and the additional point mutations Ala149Pro, 
Ile152Leu, Ser153Ala, Leu161Ile, and Ile164Val (equivalent to Ala83Pro, Ile86Leu, 
Ser87Ala, Leu95Ile, and Ile98Val in reference (Interlandi, Wetzel et al. 2008)). 
Mutations Ala149Pro, Ser153Ala, and Leu161Ile occupy buried hydrophobic pockets at 
the interface between the last internal repeat and the C-terminal capping repeat, whereas 
mutations Ile152Leu and Ile164Val are partially solvent accessible (Fig. 2b). The 
mutation Ala149Pro is located at the N-terminus of helix A and replaces an internal water 
molecule in the loop region between helix A and the preceding β-strand. The Ser153Ala 
mutation was inserted because it increases the helix propensity (Interlandi, Wetzel et al. 
2008). The crystal structure of mutant 5 shows that this mutation abrogates the H-bond 
between Ser153-OG and Phe150-O at the interface between helices A and B. However, 
this mutation seems to have almost no effect on the distances between helices A and B, 
which are 5.3 Å and 5.4 Å in wild type and mutant 5, respectively (distances between 
Cα-atoms at positions 153 and 162). In NI3C mutant 5 the side chains of Leu152, Ile161 
and Val164 are penetrating deeper into the corresponding cavities with the consequence 
that the C-terminal capping repeat is pulled towards the last internal repeat. This 
reorientation of the capping repeat allows the formation of the hydrogen bonds Asn158-
ND2...Ala121-O (2.81±0.05 Å) and Asn156-ND2...Leu152-O (2.88±0.14 Å, in chains A, 
B, and D) in mutant 5, which are not seen in the wild type structure. In chain C Asn156 
participates in the formation of a crystal contact to Gly91-O of chain A. 
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NI3C mutant 6 contains the additional mutations Asp155Arg, Asn156Glu, and 
Asn158His (equivalent to Asp89Arg, Asn90Glu, and Asn92His in reference (Interlandi, 
Wetzel et al. 2008)) relative to mutant 5. Mutations Asp155Arg and Asn156Glu were 
inserted, because it was expected that the side chains of the newly introduced residues 
would form a stabilizing salt bridge as it was seen in the internal repeats of NI3C wild 
type. (Interlandi, Wetzel et al. 2008) However, in all chains of  NI3C mutant 6 the 
distances between the guanidinium groups of Arg155 and the carboxylate groups of 
Glu156 were larger than 4 Å, suggesting that no salt bridges were formed under the given 
crystallization conditions. Furthermore, the Asn156Glu mutation abrogates the hydrogen 
bond between the Asn156 side chain and the main chain of Leu152, which was observed 
in NI3C mutant 5. Mutation Asn158His allows the formation of the hydrogen bond 
His158-ND1...Ala122-O (2.91±009 Å) that links the C-terminal capping repeat to the last 
internal repeat as it was already seen in mutant 5 for Asn158 (Fig. 2c). In general residues 
155 to 158 are rather flexible in the NI3C mutant 5 and -6 crystal structures and 
consequently show different conformations and weak electron densities in some NCS 
related molecules.  
Impact of precipitating agent on crystal twinning 
Some full-consensus DARPins are prone to form twinned crystal lattices. NI3C mutant 5 
crystallized from sodium citrate/PEG conditions and initial data sets were indexed 
assuming a hexagonal crystal lattice. Since the structure could not be refined using the 
hexagonal settings and because data statistics suggested pseudo-merohedral twinning, the 
structure was refined assuming the trigonal space group P3121, twin law (-h, -k, l) and 4 
molecules in the asymmetric unit.  Twining is often difficult to assign in the presence of 
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none-crystallographic symmetry. Therefore we used the RvR plot (Lebedev, Vagin et al. 
2006) to investigate the agreement between the observed diffraction data and the refined 
structure. Values for Robstwin  of 0.17 and for Rcalctwin  of 0.30 confirmed our assumption 
of  pseudo-merohedral twinning in the presence of rotational NCS. The relatively low 
Rcalctwin  value agrees very well with a twinning fraction of 0.374. 
Besides NI3C mutant 5 also the NI3C wild type (Merz, Wetzel et al. 2008) initially 
yielded twinned crystals when sodium citrate was used as precipitating agent (PREM 
unpublished observation). For the wild type NI3C twinning was overcome by replacing 
sodium citrate against ammonium sulphate. NI1C mutant 4 and NI3C mutant 6 also 
crystallized from ammonium sulphate solutions and these crystals were not twinned. 
Analysis of the crystal lattices revealed that sodium citrate causes the formation of crystal 
contacts involving N-cap/N-cap* and C-cap/C-cap* stacking interactions, whereas all 
crystals originating from ammonium sulphate conditions only show N-cap/C-cap* 
stacking interactions (* refers to the symmetry related molecule). In addition well-defined 
sulphate ions were identified in the electron density maps during the refinement 
processes. In NI1C mutant 4 one sulphate ion was observed in a crystal contact close to 
helix A from the internal repeat (Fig. 1a), whereas in NI3C mutant 6 three sulphate ions 
occupy similar positions like in NI3C wild type (Fig. 2a). However, in NI3C mutant 6 the 
sulphate ions are not directly involved in crystal contacts. 
Discussion 
Redesign of the interface between the last internal repeat and the C-terminal capping 
repeat significantly improved stability of full-consensus DARPins (Interlandi, Wetzel et 
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al. 2008; Wetzel, Settanni et al. 2008) and the crystal structures of NI1C mutant 4, NI3C 
mutant 5 and NI3C mutant 6 reveal the molecular determinants for this stabilization. The 
mutation Ala149Pro places a proline residue at the N-terminus of helix A. At this 
position proline participates in the hydrogen bonding network of helix A and improves 
helix formation due to its restricted φ-value. Furthermore mutations  Ile152Leu, 
Leu161Ile, and Ile164Val enable a tighter packing of the C-terminal capping repeat onto 
the last internal repeat. Altogether these mutations allow for a reorientation of the 
capping repeat that in a first approximation moves as a rigid body. This movement can be 
described as a 7° hinge movement of the capping repeat towards the last internal repeat 
and an equal rotation along the axis of the stacked repeats. The additional hydrogen bond 
between Asn158-ND2 and Ala121-O is a consequence of this reorientation because the 
capping repeat adopts the same conformation in mutant 6 although this hydrogen bond is 
disrupted by the Asn158Glu mutation. Thus, the C-terminal capping repeats of mutants 5 
and -6 provide larger interface areas, improved surface complementarities and 
consequently superior shielding of the hydrophobic core against the solvent compared to 
NI3C wild type. The improved stability is reflected by significantly weaker B-factor 
gradients. The NI3-parts (residues 13 to 142) and C-terminal repeats (residues 143 to 169) 
reveal average B-factors of 31.7±0.4 Å2 and 33.1±1.6 Å2 in mutant 5, 31.5±2.9 Å2 and 
39.4±3.5 Å2 in mutant 6, but 23.0 Å2 and 34.1 Å2 in NI3C wild type.  
Even though none of the mutations discussed above have been implemented in NI1C 
mutant 4, this mutant shows improved structural stability over NI1C wild type as judged 
by GdnHCl-induced unfolding experiments (Interlandi, Wetzel et al. 2008) and almost no 
B-factor gradient. The improved stability of the capping repeat can be addressed to the 
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extension of helix B, which provides a C-terminal helix cap (Lys101) and additional 
VdW contacts with the preceding internal repeat. Whether the conformation of His52 
also contributes to the improved stability remains questionable, because its movement 
can't be addressed to the extension of helix B. The altered side chain rotamer of His52 
could be a consequence of modified crystallization conditions, particularly the addition of 
methanol. NI1C was crystallized under acidic conditions (pH 5.0) and in the presence of 
30 % methanol, whereas all NI3C crystals were obtained in the absence of methanol and 
under different pH conditions (mutant 5 at pH 4.1, mutant 6 at pH 5.5, wild type at pH 
8.5). Since all NI3C structures reveal similar conformations of His118 (the equivalent to 
His52) its side chain conformation is independent from the pH of the crystallization 
condition.  
In all full-consensus DARPin structures the N- and C-terminal caps are involved in 
crystal contacts. In the crystal lattices of none-twinned NI3C wild type, NI1C mutant 4 
and NI3C mutant 6 crystal contacts are formed by N-cap/C-cap* stacking interactions, 
whereas in the crystal lattice of twinned NI3C mutant 5 crystal contacts are formed by N-
cap/N-cap* and C-cap/C-cap* stacking interactions. The crystal lattices of NI3C wild 
type and NI3C mutant 6 are almost isomorphous, since both crystals belong to space 
group P61 with a unit cell c-axis of approximately 50 Å and similar super-helical crystal 
packings of NI3C molecules. Thus, in the case of full-consensus DARPins the 
precipitating agent ammonium sulphate causes the formation of crystal lattices involving 
N-cap/C-cap* stacking interactions and these lattices seem to be less prone to form 
twinned crystals. Furthermore, an implication of the crystal lattice on the interface 
between the last internal repeat and the C-terminal capping repeat can be ruled out, 
Structural Determinants improving the thermal stability of DARPins  Manuscript   
 98 
because NI3C wild type and mutant 6 show significantly different interfaces although the 
crystal contacts are almost identical, vice versa NI3C mutants 5 and -6 show very similar 
interfaces although the crystal contacts are significantly different.  
The crystal structures of NI1C mutant 4, NI3C mutant 5 and NI3C mutant 6 presented 
above, illustrate the success of the consensus sequence approach for the design of new C-
terminal capping repeats. (Interlandi, Wetzel et al. 2008) From a pure structural point of 
view the extension of helix B by Lys101, Ala102 and Ala103, the replacement of alanine 
against Pro83 at the N-terminus of  helix A and the introduction of the optimized 
interface residues Leu86, Ile95 and Val98 contribute significantly to the improved 
stability of the new C-cap design. Whether the increased helix propensity of the Ser87Ala 
mutation improves the stability can not be deduced from the crystal structures alone. 
Ser87 could still be beneficial for the stability of helix A. The mutations Asp89Arg and 
Asn90Glu were introduced, expecting that the Arg89...Glu90 salt bridge would stabilize 
the cap. Under the given crystallization conditions for NI3C mutant 6 no such interaction 
was observed. Thus, although the new C-terminal capping repeat design of Interlandi et 
al. (2008) is superior over the initial design there is still room for further improvement. 
Material and Methods 
Protein purification and crystallization 
NI1C mutant 4 and NI3C mutants 5 and -6 were expressed in E. coli and purified as 
described previously. (Binz, Amstutz et al. 2004) Size-exclusion chromatography was 
performed in 10 mM HEPES, pH 6.5, 20 mM NaCl on a Hi-Load 26/60 Superdex-75 
column (GE Healthcare) mounted on an Äekta Prime system (GE Healthcare). The 
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proteins were concentrated to 30 mg/mL using Centricon (Millipore USA) ultra-filtration 
devises (3 kDa molecular mass cutoff). Crystals were grown using the sitting drop-vapor 
diffusion method at 20°C in 24-well crystallization plates. Proteins and reservoir 
solutions were mixed at 2 µL to 1µL ratios. Crystallization conditions are given in Table 
2. Crystals were soaked in the reservoir buffers supplemented with 30 % glycerol as 
cryo-protectant and flash-cooled in a nitrogen stream at 100 K. 
X-ray data collection and refinement 
X-ray diffraction data were measured at the PX6 beam-line at the Swiss Light Source 
(Villingen, CH) using the Pilatus detector. For each structure 360 frames were recorded 
with an oscillation range of 0.5° per frame. Data were processed using the program XDS. 
(Kabsch 1993) Twinning of X-ray diffraction data was analyzed using the program 
phenix.xtriage. (Adams, Grosse-Kunstleve et al. 2002) Initial phases were determined by 
molecular replacement using program Phaser (McCoy, Grosse-Kunstleve et al. 2007) 
with the structures of the full-consensus NI3C wild type (pdb code: 2QYJ)(Merz, Wetzel 
et al. 2008) or the three-repeat ankyrin repeat protein 3CA1A2 (pdb code: 2ZGD)(Kelly, 
McDonough et al. 2009) as search models. Structures were refined using the programs 
PHENIX (Adams, Grosse-Kunstleve et al. 2002) and COOT (Emsley and Cowtan 2004). 
NI3C mutant 5 was refined using the twin law (-h, -k, l) with a twinning fraction of 0.374. 
The qualities of the structures were evaluated with the programs MOLPROBITY and 
PROCHECK (Laskowski, Moss et al. 1993; Davis, Leaver-Fay et al. 2007). To 
investigate the intra-molecular shape complementarities we used the program SC 
(Lawrence 1993), which was originally developed to calculate the shape 
Structural Determinants improving the thermal stability of DARPins  Manuscript   
 100 
complementarities between independent subunits. Therefore separate coordinate files 
were prepared by splitting the DARPin structures at the repeat boundaries (residues 76/77 
for NI1C and residues 142/143 for NI3C). PYMOL (DeLano 2002) was used to prepare 
figures. 
Accession numbers 
Coordinates and structure factors have been deposited at the Macromolecular Structure 
database with accession number XXX (NI1C mutant4), XXX (NI3C mutant 5), and XXX 
(NI3C mutant 6),  
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Figure legends 
Figure 1. (a) Ribbon diagrams of NI1C mutant 4. N-terminal capping repeat, internal 
repeat and C-terminal capping repeat are coloured salmon, green and blue, respectively. 
The N-terminus and the last amino acid of every repeat is labelled. (b) Wall-eye stereo 
plot of the superposition of the last internal repeat and the C-terminal capping repeat of 
NI1C (light blue) onto the corresponding repeats of NI3C wild type (magenta, pdb-id: 
2qyj). Amino acid numbering refers to NI1C with the exception of Thr115, which is 
shown in italics.  
Figure 2. (a) Ribbon diagrams of NI3C mutant 6. Colour coding according to Fig. 1a. (b) 
Wall-eye stereo plot of the superposition of NI3C-mutant 5 (cyan) onto NI3C wild type 
(magenta). Residues 13-142 of mutant 5 are depicted as a molecular surface (grey) and 
the C-terminal capping repeats as Cα-traces. Residue nomenclature follows the sequence 
of NI3C mutant 5. (c) Superposition of C-terminus of NI3C mutant 6 (green carbon 
atoms) onto NI3C mutant 5 (blue carbon atoms). Different shades of blue indicate the 
repeat boundaries (light blue: internal repeat; cyan: C-terminal capping repeat). 
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Tables 
Table 1. Sequence and structural parameters of full-consensus DARPins 
Repeat Sequence‡  Tm
*  
(C) 
Burie
d 
area 
(Å2)†  
Surface 
complementarities
†
 
N-cap  --
DLGKKLLEAARAGQDDEVRILMANGADVNAK 
   
interna
l 
DKDGYTPLHLAAREGHLEIVEVLLKAGADVNA
K 
   
C-cap     
wild 
type 
DKFGKTAFDISIDNGNEDLAEILQ--------
- 
60° 625 0.705  
mutant 
4 
DKFGKTAFDISIDNGNEDLAEILQKAA-----
- 
64° 654 0.711 
mutant 
5 
DKFGKTPFDLAIDNGNEDIAEVLQKAA-----
- 
77° 720 ± 
6  
0.801 
mutant 
6 
DKFGKTPFDLAIREGHEDIAEVLQKAA-----
- 
77° 723 ± 
6 
0.802 
‡ Residues participating in α-helices are indicated in bold and mutated residues in red 
characters. 
* Melting temperature of NI1C wild type and mutants, taken from (Interlandi, Wetzel et 
al. 2008). 
†
 Buried surface area and surface complementarities between last internal repeat and C-
terminal capping repeat. Errors represent standard deviations between values of NCS-
related molecules.  
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Table 2. Crystallization parameters and refinement statistics 
  NI1C mutant 4 NI3C mutant 5 NI3C mutant 6 
        
Data collection    
space group C2 P3121 P61 
molecules/asymmetric unit 1 4 3 
unit cell parameters (Å) a=77.15,  b= 35.33,   c=32.40   a=62.05, b=62.05, c=270.18 a=128.91, b=128.91, c=50.70  
 α=90°, β=114.43°,  γ=90°  α=90°, β=90°, γ=120° α=90°, β=90°, γ=120° 
     
resolution limit (Å) 31 - 2.2 50 – 2.1  50 -1.8 
observed reflections 4117 35848 82387 
completeness (%)* 98.8 (98.3) 98.2 (94.7) 99.4 (96.5) 
redundancy (%)* 6.10 (6.38) 5.63 (5.13) 6.3 (6.0) 
Rsym (% on I)* 5.8 (13.1) 9.1 (39.4) 6.6 (22.7) 
     
Refinement    
resolution range (Å) 31 - 2.2 50 – 2.1  46 -1.8 
Rwork (%) 16.81 17.53 21.68 
Rfree (%) 22.24 24.00 24.97 
     
ordered water molecules 53 175 257 
protein atoms 684 4742 3583 
sulphates 1 0 9 
methanol 1 0 0 
     
rmsd of bond lengths 0.008 0.002 0.004 
rmsd of bond angles 0.944 0.460 0.803 
average B-factor 23.7 31.65 31.66 
     
Ramachandran plot    
most favored (%) 95.0 90.0 91.2 
additional allowed (%) 5.0 10.0 8.8 
generously allowed (%) 0.0 0.0 0.0 
disallowed (%) 0.0 0.0 0.0 
     
     
Crystallization conditions 
 
0.05 M sodium succinate, 
pH 4.0 
2.9 M ammonium sulphate 
30% methanol 
0.1M sodium citrate, 
pH 4.1 
1.2 M lithium chloride 
30 % PEG 6000 
0.1 M HEPES, 
pH 5.5 
0.1 M L-cysteine 
2.9 M ammonium sulphate 
 
* Values in parenthesis refer to the outermost resolution shell.  
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Figures 
a.  
b.  
Figure 1.  
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c.  
Figure 2. 
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D) Appendices 
 
Medium for bacterial growth 
 
LB media 
10g Bacto-tryptone  
5g Bacto-yeast extract 
10g NaCl 
1 l H2O 
 
2YT media 
16g Bacto-tryptone 
10g yeast extract 
5g NaCl 
1l H2O 
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Mac Kinnon Screen 3 
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Additive Screen 
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